| Year |
Citation |
Score |
| 2024 |
Li Y, Yen D, Hendrix RD, Gordon BA, Dlamini S, Barthélemy NR, Aschenbrenner AJ, Henson RL, Herries EM, Volluz K, Kirmess K, Eastwood S, Meyer M, Heller M, Jarrett L, ... ... Morris JC, et al. Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset. Annals of Neurology. PMID 38400792 DOI: 10.1002/ana.26891 |
0.553 |
|
| 2024 |
Barthélemy NR, Salvadó G, Schindler S, He Y, Janelidze S, Collij LE, Saef B, Henson RL, Chen CD, Gordon BA, Li Y, La Joie R, Benzinger TLS, Morris JC, Mattsson-Carlgren N, et al. Highly Accurate Blood Test for Alzheimer's Disease Comparable or Superior to Clinical CSF Tests. Nature Medicine. PMID 38382645 DOI: 10.1038/s41591-024-02869-z |
0.586 |
|
| 2024 |
Joseph-Mathurin N, Feldman RL, Lu R, Shirzadi Z, Toomer C, Saint Clair JR, Ma Y, McKay NS, Strain JF, Kilgore C, Friedrichsen KA, Chen CD, Gordon BA, Chen G, Hornbeck RC, ... ... Morris JC, et al. Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38380882 DOI: 10.1002/alz.13729 |
0.533 |
|
| 2024 |
Welhaf MS, Wilks H, Aschenbrenner AJ, Balota DA, Schindler SE, Benzinger TLS, Gordon BA, Cruchaga C, Xiong C, Morris JC, Hassenstab J. Naturalistic assessment of reaction time variability in older adults at risk for Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 1-11. PMID 38282413 DOI: 10.1017/S1355617723011475 |
0.566 |
|
| 2024 |
Shen Y, Ali M, Timsina J, Wang C, Do A, Western D, Liu M, Gorijala P, Budde J, Liu H, Gordon B, McDade E, Morris JC, Llibre-Guerra JJ, Bateman RJ, et al. Systematic proteomics in Autosomal dominant Alzheimer's disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathways. Medrxiv : the Preprint Server For Health Sciences. PMID 38260583 DOI: 10.1101/2024.01.12.24301242 |
0.536 |
|
| 2023 |
Chen G, McKay NS, Gordon BA, Liu J, Joseph-Mathurin N, Schindler SE, Hassenstab J, Aschenbrenner AJ, Wang Q, Schultz SA, Su Y, LaMontagne PJ, Keefe SJ, Massoumzadeh P, Cruchaga C, ... ... Morris JC, et al. Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change? Neuroimage. Clinical. 41: 103551. PMID 38150745 DOI: 10.1016/j.nicl.2023.103551 |
0.551 |
|
| 2023 |
Millar PR, Gordon BA, Wisch JK, Schultz SA, Benzinger TL, Cruchaga C, Hassenstab JJ, Ibanez L, Karch C, Llibre-Guerra JJ, Morris JC, Perrin RJ, Supnet-Bell C, Xiong C, Allegri RF, et al. Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease. Molecular Neurodegeneration. 18: 98. PMID 38111006 DOI: 10.1186/s13024-023-00688-3 |
0.533 |
|
| 2023 |
Tu JC, Millar PR, Strain JF, Eck A, Adeyemo B, Daniels A, Karch C, Huey ED, McDade E, Day GS, Yakushev I, Hassenstab J, Morris J, Llibre-Guerra JJ, Ibanez L, et al. Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease. Biorxiv : the Preprint Server For Biology. PMID 37961586 DOI: 10.1101/2023.10.29.564633 |
0.558 |
|
| 2023 |
Llibre-Guerra JJ, Iaccarino L, Coble D, Edwards L, Li Y, McDade E, Strom A, Gordon B, Mundada N, Schindler SE, Tsoy E, Ma Y, Lu R, Fagan AM, Benzinger TLS, ... ... Morris JC, et al. Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 5: fcad280. PMID 37942088 DOI: 10.1093/braincomms/fcad280 |
0.59 |
|
| 2023 |
Rahmani F, Brier MR, Gordon BA, McKay N, Flores S, Keefe S, Hornbeck R, Ances B, Joseph-Mathurin N, Xiong C, Wang G, Raji CA, Libre-Guerra JJ, Perrin RJ, McDade E, ... ... Morris JC, et al. T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease. Human Brain Mapping. PMID 37867465 DOI: 10.1002/hbm.26514 |
0.528 |
|
| 2023 |
Shirzadi Z, Schultz SA, Yau WW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, Kantarci K, Preboske GM, Jack CR, Farlow MR, Hassenstab J, Jucker M, Morris JC, Xiong C, Karch CM, et al. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. Jama Neurology. PMID 37843849 DOI: 10.1001/jamaneurol.2023.3618 |
0.57 |
|
| 2023 |
Wagemann O, Li Y, Hassenstab J, Aschenbrenner AJ, McKay NS, Gordon BA, Benzinger TLS, Xiong C, Cruchaga C, Renton AE, Perrin RJ, Berman SB, Chhatwal JP, Farlow MR, Day GS, ... ... Morris JC, et al. Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37740921 DOI: 10.1002/alz.13460 |
0.567 |
|
| 2023 |
Johnson ECB, Bian S, Haque RU, Carter EK, Watson CM, Gordon BA, Ping L, Duong DM, Epstein MP, McDade E, Barthélemy NR, Karch CM, Xiong C, Cruchaga C, Perrin RJ, ... ... Morris JC, et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease. Nature Medicine. PMID 37550416 DOI: 10.1038/s41591-023-02476-4 |
0.586 |
|
| 2023 |
Salvadó G, Horie K, Barthélemy NR, Vogel JW, Binette AP, Chen CD, Aschenbrenner AJ, Gordon BA, Benzinger TLS, Holtzman DM, Morris JC, Palmqvist S, Stomrud E, Janelidze S, Ossenkoppele R, et al. Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease. Medrxiv : the Preprint Server For Health Sciences. PMID 37503281 DOI: 10.1101/2023.07.14.23292650 |
0.596 |
|
| 2023 |
Horie K, Salvadó G, Barthélemy NR, Janelidze S, Li Y, He Y, Saef B, Chen CD, Jiang H, Strandberg O, Pichet Binette A, Palmqvist S, Sato C, Sachdev P, Koyama A, ... ... Morris JC, et al. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nature Medicine. PMID 37443334 DOI: 10.1038/s41591-023-02443-z |
0.547 |
|
| 2023 |
McKay NS, Gordon BA, Hornbeck RC, Dincer A, Flores S, Keefe SJ, Joseph-Mathurin N, Jack CR, Koeppe R, Millar PR, Ances BM, Chen CD, Daniels A, Hobbs DA, Jackson K, ... ... Morris JC, et al. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nature Neuroscience. PMID 37429916 DOI: 10.1038/s41593-023-01359-8 |
0.561 |
|
| 2023 |
Schultz SA, Shirzadi Z, Schultz AP, Liu L, Fitzpatrick CD, McDade E, Barthelemy NR, Renton A, Esposito B, Joseph-Mathurin N, Cruchaga C, Chen CD, Goate A, Allegri RF, Benzinger TLS, ... ... Morris JC, et al. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. Aging Cell. e13871. PMID 37291760 DOI: 10.1111/acel.13871 |
0.572 |
|
| 2023 |
Luo J, Ma Y, Agboola FJ, Grant E, Morris JC, McDade E, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Gordon BA, Goyal M, Strain JF, Yakushev I, et al. Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Lifespan. Neurology. PMID 37202169 DOI: 10.1212/WNL.0000000000207378 |
0.594 |
|
| 2023 |
Barthélemy NR, Saef B, Li Y, Gordon BA, He Y, Horie K, Stomrud E, Salvadó G, Janelidze S, Sato C, Ovod V, Henson RL, Fagan AM, Benzinger TLS, Xiong C, ... Morris JC, et al. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease. Nature Aging. 3: 391-401. PMID 37117788 DOI: 10.1038/s43587-023-00380-7 |
0.555 |
|
| 2023 |
Ali M, Archer DB, Gorijala P, Western D, Timsina J, Fernández MV, Wang TC, Satizabal CL, Yang Q, Beiser AS, Wang R, Chen G, Gordon B, Benzinger TLS, Xiong C, ... Morris JC, et al. Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease. Acta Neuropathologica Communications. 11: 68. PMID 37101235 DOI: 10.1186/s40478-023-01563-4 |
0.5 |
|
| 2023 |
Xu Y, Aung HL, Bateman RJ, Brooks WS, Chhatwal J, Day GS, Fagan AM, Farlow MR, Gordon B, Kehoe PG, Levin J, Mori H, Morris JC, Wharton W, Humburg P, et al. Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37087693 DOI: 10.1002/alz.13082 |
0.525 |
|
| 2023 |
Grober E, Petersen KK, Lipton RB, Hassenstab J, Morris JC, Gordon BA, Ezzati A. Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals. Neurology. PMID 37076305 DOI: 10.1212/WNL.0000000000207276 |
0.491 |
|
| 2023 |
Wisch JK, Babulal GM, Petersen K, Millar PR, Shacham E, Scroggins S, Boerwinkle AH, Flores S, Keefe S, Gordon BA, Morris JC, Ances BM. A practitioner's guide to geospatial analysis in a neuroimaging context. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12413. PMID 36935765 DOI: 10.1002/dad2.12413 |
0.405 |
|
| 2023 |
Wisch JK, Gordon BA, Boerwinkle AH, Luckett PH, Bollinger JG, Ovod V, Li Y, Henson RL, West T, Meyer MR, Kirmess KM, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ, et al. Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12405. PMID 36874595 DOI: 10.1002/dad2.12405 |
0.545 |
|
| 2023 |
Horie K, Li Y, Barthélemy NR, Gordon BA, Hassenstab J, Benzinger TLS, Fagan AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, Ikeuchi T, Kasuga K, Noble J, et al. Change in cerebrospinal fluid tau microtubule binding region detects symptom onset, cognitive decline, tangles, and atrophy in Dominantly Inherited Alzheimer's Disease. Annals of Neurology. PMID 36843330 DOI: 10.1002/ana.26620 |
0.578 |
|
| 2023 |
Xiong C, McCue LM, Buckles V, Grant E, Agboola F, Coble D, Bateman RJ, Fagan AM, Benzinger TLS, Hassenstab J, Schindler SE, McDade E, Moulder K, Gordon BA, Cruchaga C, ... ... Morris JC, et al. Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36640138 DOI: 10.1002/alz.12912 |
0.575 |
|
| 2023 |
Wheelock MD, Strain JF, Mansfield P, Tu JC, Tanenbaum A, Preische O, Chhatwal JP, Cash DM, Cruchaga C, Fagan AM, Fox NC, Graff-Radford NR, Hassenstab J, Jack CR, Karch CM, ... ... Morris JC, et al. Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease. Brain : a Journal of Neurology. PMID 36625756 DOI: 10.1093/brain/awac498 |
0.479 |
|
| 2023 |
Millar PR, Gordon BA, Luckett PH, Benzinger TLS, Cruchaga C, Fagan AM, Hassenstab J, Perrin RJ, Schindler SE, Allegri RF, Day GS, Farlow MR, Mori H, Nübling G, Bateman RJ, ... Morris JC, et al. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study. Elife. 12. PMID 36607335 DOI: 10.7554/eLife.81869 |
0.546 |
|
| 2022 |
Chatterjee P, Vermunt L, Gordon BA, Pedrini S, Boonkamp L, Armstrong NJ, Xiong C, Singh AK, Li Y, Sohrabi HR, Taddei K, Molloy M, Benzinger TLS, Morris JC, Karch C, et al. Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36576155 DOI: 10.1002/alz.12879 |
0.585 |
|
| 2022 |
Wisch JK, Butt OH, Gordon BA, Schindler SE, Fagan AM, Henson RL, Yang C, Boerwinkle AH, Benzinger TLS, Holtzman DM, Morris JC, Cruchaga C, Ances BM. Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression. Brain : a Journal of Neurology. PMID 36542469 DOI: 10.1093/brain/awac484 |
0.611 |
|
| 2022 |
O'Connor A, Rice H, Barnes J, Ryan NS, Liu KY, Allegri RF, Berman S, Ringman JM, Cruchaga C, Farlow MR, Hassenstab J, Lee JH, Perrin RJ, Xiong C, Gordon B, ... ... Morris JC, et al. First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 36522155 DOI: 10.1136/jnnp-2022-329843 |
0.537 |
|
| 2022 |
Dincer A, Chen CD, McKay NS, Koenig LN, McCullough A, Flores S, Keefe SJ, Schultz SA, Feldman RL, Joseph-Mathurin N, Hornbeck RC, Cruchaga C, Schindler SE, Holtzman DM, Morris JC, et al. APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression. Science Translational Medicine. 14: eabl7646. PMID 36383681 DOI: 10.1126/scitranslmed.abl7646 |
0.498 |
|
| 2022 |
Warren-Gash C, Cadogan SL, Nicholas JM, Breuer JM, Shah D, Pearce N, Shiekh S, Smeeth L, Farlow MR, Mori H, Gordon BA, Nuebling G, McDade E, Bateman RJ, Schofield PR, ... ... Morris JC, et al. Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network. Annals of Clinical and Translational Neurology. PMID 36189728 DOI: 10.1002/acn3.51669 |
0.48 |
|
| 2022 |
Hartz SM, Mozersky J, Schindler SE, Linnenbringer E, Wang J, Gordon BA, Raji CA, Moulder KL, West T, Benzinger TLS, Cruchaga C, Hassenstab JJ, Bierut LJ, Xiong C, Morris JC. A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36178120 DOI: 10.1002/alz.12781 |
0.585 |
|
| 2022 |
Nicosia J, Aschenbrenner AJ, Balota DA, Sliwinski MJ, Tahan M, Adams S, Stout SS, Wilks H, Gordon BA, Benzinger TLS, Fagan AM, Xiong C, Bateman RJ, Morris JC, Hassenstab J. Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 1-13. PMID 36062528 DOI: 10.1017/S135561772200042X |
0.522 |
|
| 2022 |
Flores S, Chen CD, Su Y, Dincer A, Keefe SJ, McKay NS, Paulick AM, Perez-Carillo GG, Wang L, Hornbeck RC, Goyal M, Vlassenko A, Schwarz S, Nickels ML, Wong DF, ... ... Morris JC, et al. Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35953305 DOI: 10.2967/jnumed.122.263948 |
0.483 |
|
| 2022 |
Luo J, Agboola F, Grant E, Morris JC, Masters CL, Albert MS, Johnson SC, McDade EM, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Wang G, Li Y, et al. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. Brain : a Journal of Neurology. PMID 35925685 DOI: 10.1093/brain/awac238 |
0.588 |
|
| 2022 |
Strain JF, Brier MR, Tanenbaum A, Gordon BA, McCarthy JE, Dincer A, Marcus DS, Chhatwal JP, Graff-Radford NR, Day GS, la Fougère C, Perrin RJ, Salloway S, Schofield PR, Yakushev I, ... ... Morris JC, et al. Covariance-based vs. Correlation-based Functional Connectivity Dissociates Healthy Aging from Alzheimer Disease. Neuroimage. 119511. PMID 35914670 DOI: 10.1016/j.neuroimage.2022.119511 |
0.517 |
|
| 2022 |
Strikwerda-Brown C, Hobbs DA, Gonneaud J, St-Onge F, Binette AP, Ozlen H, Provost K, Soucy JP, Buckley RF, Benzinger TLS, Morris JC, Villemagne VL, Doré V, Sperling RA, Johnson KA, et al. Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. Jama Neurology. PMID 35907254 DOI: 10.1001/jamaneurol.2022.2379 |
0.603 |
|
| 2022 |
Long JM, Coble DW, Xiong C, Schindler SE, Perrin RJ, Gordon BA, Benzinger TLS, Grant E, Fagan AM, Harari O, Cruchaga C, Holtzman DM, Morris JC. Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes. Brain : a Journal of Neurology. PMID 35867858 DOI: 10.1093/brain/awac250 |
0.615 |
|
| 2022 |
Hwang G, Abdulkadir A, Erus G, Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Rashid T, Bilgel M, Fan Y, Sotiras A, Srinivasan D, Morris JC, Albert MS, et al. Disentangling Alzheimer's disease neurodegeneration from typical brain ageing using machine learning. Brain Communications. 4: fcac117. PMID 35611306 DOI: 10.1093/braincomms/fcac117 |
0.321 |
|
| 2022 |
Morris JC, Weiner M, Xiong C, Beckett L, Coble D, Saito N, Aisen PS, Allegri R, Benzinger TLS, Berman SB, Cairns NJ, Carrillo MC, Chui HC, Chhatwal JP, Cruchaga C, et al. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain : a Journal of Neurology. PMID 35580594 DOI: 10.1093/brain/awac181 |
0.616 |
|
| 2022 |
Millar PR, Luckett PH, Gordon BA, Benzinger TL, Schindler SE, Fagan AM, Cruchaga C, Bateman RJ, Allegri R, Jucker M, Lee JH, Mori H, Salloway SP, Yakushev I, Morris JC, et al. Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease. Neuroimage. 119228. PMID 35452806 DOI: 10.1016/j.neuroimage.2022.119228 |
0.544 |
|
| 2022 |
Schindler SE, Karikari TK, Ashton NJ, Henson RL, Yarasheski KE, West T, Meyer MR, Kirmess KM, Li Y, Saef B, Moulder KL, Bradford D, Fagan AM, Gordon BA, Benzinger TLS, ... ... Morris JC, et al. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light. Neurology. PMID 35450967 DOI: 10.1212/WNL.0000000000200358 |
0.509 |
|
| 2022 |
Luckett PH, Chen C, Gordon BA, Wisch J, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, Fox NC, Jucker M, Levin J, Masters CL, Mori H, Noble JM, ... ... Morris JC, et al. Biomarker clustering in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35362200 DOI: 10.1002/alz.12661 |
0.569 |
|
| 2022 |
Strain JF, Barthelemy N, Horie K, Gordon BA, Kilgore C, Aschenbrenner A, Cruchaga C, Xiong C, Joseph-Mathurin N, Hassenstab J, Fagan AM, Li Y, Karch CM, Perrin RJ, Berman SB, ... ... Morris JC, et al. CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease. Neurobiology of Disease. 168: 105714. PMID 35358703 DOI: 10.1016/j.nbd.2022.105714 |
0.565 |
|
| 2022 |
Morenas-Rodríguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Suárez-Calvet M, Fagan AM, Schultz S, Gordon BA, Benzinger TLS, Hassenstab J, McDade E, Feederle R, Karch CM, Schlepckow K, ... Morris JC, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study. The Lancet. Neurology. 21: 329-341. PMID 35305339 DOI: 10.1016/S1474-4422(22)00027-8 |
0.614 |
|
| 2022 |
Wang Q, Chen G, Schindler SE, Christensen J, McKay NS, Liu J, Wang S, Sun Z, Hassenstab J, Su Y, Flores S, Hornbeck R, Cash L, Cruchaga C, Fagan AM, ... ... Morris JC, et al. Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 35260470 DOI: 10.1212/NXI.0000000000001152 |
0.308 |
|
| 2022 |
McKay NS, Dincer A, Mehrotra V, Aschenbrenner AJ, Balota D, Hornbeck RC, Hassenstab J, Morris JC, Benzinger TLS, Gordon BA. Beta-amyloid moderates the relationship between cortical thickness and attentional control in middle- and older-aged adults. Neurobiology of Aging. 112: 181-190. PMID 35227946 DOI: 10.1016/j.neurobiolaging.2021.12.012 |
0.542 |
|
| 2022 |
Meeker KL, Butt OH, Gordon BA, Fagan AM, Schindler SE, Morris JC, Benzinger TLS, Ances BM. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage. Neurobiology of Disease. 105662. PMID 35167933 DOI: 10.1016/j.nbd.2022.105662 |
0.526 |
|
| 2022 |
Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, ... ... Morris JC, et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. The Lancet. Neurology. 21: 140-152. PMID 35065037 DOI: 10.1016/S1474-4422(21)00375-6 |
0.583 |
|
| 2022 |
Wilks H, Aschenbrenner AJ, Gordon BA, Balota DA, Fagan AM, Musiek E, Balls-Berry J, Benzinger TLS, Cruchaga C, Morris JC, Hassenstab J. Sharper in the morning: Cognitive time of day effects revealed with high-frequency smartphone testing. Journal of Clinical and Experimental Neuropsychology. 1-13. PMID 35037593 DOI: 10.1080/13803395.2021.2009447 |
0.54 |
|
| 2021 |
Koenig LN, LaMontagne P, Glasser MF, Bateman R, Holtzman D, Yakushev I, Chhatwal J, Day GS, Jack C, Mummery C, Perrin RJ, Gordon BA, Morris JC, Shimony JS, Benzinger TLS, et al. Regional age-related atrophy after screening for preclinical alzheimer disease. Neurobiology of Aging. 109: 43-51. PMID 34655980 DOI: 10.1016/j.neurobiolaging.2021.09.010 |
0.494 |
|
| 2021 |
Hassenstab J, Nicosia J, LaRose M, Aschenbrenner AJ, Gordon BA, Benzinger TLS, Xiong C, Morris JC. Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease. Alzheimer's Research & Therapy. 13: 153. PMID 34517889 DOI: 10.1186/s13195-021-00894-5 |
0.559 |
|
| 2021 |
Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, et al. Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nature Communications. 12: 5346. PMID 34504080 DOI: 10.1038/s41467-021-25492-9 |
0.574 |
|
| 2021 |
Schindler S, Li Y, Buckles VD, Gordon BA, Benzinger TLS, Wang G, Coble D, Klunk WE, Fagan AM, Holtzman D, Bateman RJ, Morris JC, Xiong C. Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET. Neurology. PMID 34504028 DOI: 10.1212/WNL.0000000000012775 |
0.577 |
|
| 2021 |
Chen CD, Joseph-Mathurin N, Sinha N, Zhou A, Li Y, Friedrichsen K, McCullough A, Franklin EE, Hornbeck R, Gordon B, Sharma V, Cruchaga C, Goate A, Karch C, McDade E, ... ... Morris JC, et al. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease. Acta Neuropathologica. PMID 34319442 DOI: 10.1007/s00401-021-02342-y |
0.495 |
|
| 2021 |
Keret O, Staffaroni AM, Ringman JM, Cobigo Y, Goh SM, Wolf A, Allen IE, Salloway S, Chhatwal J, Brickman AM, Reyes-Dumeyer D, Bateman RJ, Benzinger TLS, Morris JC, Ances BM, et al. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12197. PMID 34258377 DOI: 10.1002/dad2.12197 |
0.563 |
|
| 2021 |
Keret O, Staffaroni AM, Ringman JM, Cobigo Y, Goh SM, Wolf A, Allen IE, Salloway S, Chhatwal J, Brickman AM, Reyes-Dumeyer D, Bateman RJ, Benzinger TLS, Morris JC, Ances BM, et al. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12197. PMID 34258377 DOI: 10.1002/dad2.12197 |
0.563 |
|
| 2021 |
Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, ... ... Morris JC, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine. PMID 34155411 DOI: 10.1038/s41591-021-01369-8 |
0.553 |
|
| 2021 |
Harrington KD, Aschenbrenner AJ, Maruff P, Masters CL, Fagan AM, Benzinger TLS, Gordon BA, Cruchaga C, Morris JC, Hassenstab J. Undetected Neurodegenerative Disease Biases Estimates of Cognitive Change in Older Adults. Psychological Science. 956797620985518. PMID 34043464 DOI: 10.1177/0956797620985518 |
0.512 |
|
| 2021 |
Pichet Binette A, Theaud G, Rheault F, Roy M, Collins DL, Levin J, Mori H, Lee JH, Farlow MR, Schofield P, Chhatwal JP, Masters CL, Benzinger T, Morris J, Bateman R, et al. Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease. Elife. 10. PMID 33983116 DOI: 10.7554/eLife.62929 |
0.303 |
|
| 2021 |
Boerwinkle AH, Wisch JK, Chen CD, Gordon BA, Butt OH, Schindler SE, Sutphen C, Flores S, Dincer A, Benzinger TLS, Fagan AM, Morris JC, Ances BM. Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease. Neurology. PMID 33931538 DOI: 10.1212/WNL.0000000000012123 |
0.593 |
|
| 2021 |
Butt OH, Long JM, Henson RL, Herries E, Sutphen CL, Fagan AM, Cruchaga C, Ladenson JH, Holtzman DM, Morris JC, Ances BM, Schindler SE. Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25. Neurobiology of Aging. 102: 64-72. PMID 33765432 DOI: 10.1016/j.neurobiolaging.2021.02.008 |
0.328 |
|
| 2021 |
Ewers M, Luan Y, Frontzkowski L, Neitzel J, Rubinski A, Dichgans M, Hassenstab J, Gordon BA, Chhatwal JP, Levin J, Schofield P, Benzinger TLS, Morris JC, Goate A, Karch CM, et al. Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease. Brain : a Journal of Neurology. PMID 33725114 DOI: 10.1093/brain/awab112 |
0.537 |
|
| 2021 |
Joseph-Mathurin N, Wang G, Kantarci K, Jack CR, McDade E, Hassenstab J, Blazey TM, Gordon BA, Su Y, Chen G, Massoumzadeh P, Hornbeck RC, Allegri RF, Ances BM, Berman SB, ... ... Morris JC, et al. Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease. Neurology. PMID 33495373 DOI: 10.1212/WNL.0000000000011542 |
0.5 |
|
| 2021 |
Luckett PH, McCullough A, Gordon BA, Strain J, Flores S, Dincer A, McCarthy J, Kuffner T, Stern A, Meeker KL, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, ... ... Morris JC, et al. Modeling autosomal dominant Alzheimer's disease with machine learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33480178 DOI: 10.1002/alz.12259 |
0.468 |
|
| 2021 |
Smith R, Strain J, Tanenbaum A, Fagan A, Hassenstab J, Mcdade E, Schindler S, Gordon B, Xiong C, Chhatwal J, Jack CR, Karch C, Berman S, Brosch J, Lah J, ... ... Morris J, et al. Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease. Brain Connectivity. PMID 33430685 DOI: 10.1089/brain.2020.0808 |
0.499 |
|
| 2020 |
Dincer A, Gordon BA, Hari-Raj A, Keefe SJ, Flores S, McKay NS, Paulick AM, Shady Lewis KE, Feldman RL, Hornbeck RC, Allegri R, Ances BM, Berman SB, Brickman AM, Brooks WS, ... ... Morris JC, et al. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease. Neuroimage. Clinical. 28: 102491. PMID 33395982 DOI: 10.1016/j.nicl.2020.102491 |
0.491 |
|
| 2020 |
Babulal GM, Johnson A, Fagan AM, Morris JC, Roe CM. Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept. Journal of Alzheimer's Disease : Jad. PMID 33361605 DOI: 10.3233/JAD-201294 |
0.366 |
|
| 2020 |
Mozersky J, Hartz S, Linnenbringer E, Levin L, Streitz M, Stock K, Moulder K, Morris JC. Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results. Journal of Alzheimer's Disease : Jad. PMID 33337371 DOI: 10.3233/JAD-200993 |
0.354 |
|
| 2020 |
Meeker KL, Ances BM, Gordon BA, Rudolph CW, Luckett P, Balota DA, Morris JC, Fagan AM, Benzinger TL, Waring JD. Cerebrospinal fluid Aβ42 moderates the relationship between brain functional network dynamics and cognitive intraindividual variability. Neurobiology of Aging. 98: 116-123. PMID 33264709 DOI: 10.1016/j.neurobiolaging.2020.10.027 |
0.505 |
|
| 2020 |
Chen CD, Holden TR, Gordon BA, Franklin EE, Li Y, Coble DW, Luo H, Bateman RJ, Ances BM, Perrin RJ, Benzinger TLS, Cairns NJ, Morris JC. Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease. Annals of Clinical and Translational Neurology. PMID 33150749 DOI: 10.1002/acn3.51237 |
0.548 |
|
| 2020 |
Millar PR, Ances BM, Gordon BA, Benzinger TLS, Morris JC, Balota DA. Evaluating Cognitive Relationships with Resting-State and Task-driven Blood Oxygen Level-Dependent Variability. Journal of Cognitive Neuroscience. 1-24. PMID 33135966 DOI: 10.1162/jocn_a_01645 |
0.4 |
|
| 2020 |
Meeker KL, Wisch JK, Hudson D, Coble D, Xiong C, Babulal GM, Gordon BA, Schindler SE, Cruchaga C, Flores S, Dincer A, Benzinger TL, Morris JC, Ances BM. Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework. Annals of Neurology. PMID 33111990 DOI: 10.1002/ana.25948 |
0.513 |
|
| 2020 |
Millar PR, Ances BM, Gordon BA, Benzinger TLS, Fagan AM, Morris JC, Balota DA. Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease. Neurobiology of Aging. 96: 233-245. PMID 33039901 DOI: 10.1016/J.Neurobiolaging.2020.08.007 |
0.56 |
|
| 2020 |
Denny A, Streitz M, Stock K, Balls-Berry JE, Barnes LL, Byrd GS, Croff R, Gao S, Glover CM, Hendrie HC, Hu WT, Manly JJ, Moulder KL, Stark S, Thomas SB, ... ... Morris JC, et al. Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33034414 DOI: 10.1002/Alz.12160 |
0.377 |
|
| 2020 |
Goyal MS, Gordon BA, Couture LE, Flores S, Xiong C, Morris JC, Raichle ME, L-S Benzinger T, Vlassenko AG. Spatiotemporal relationship between subthreshold amyloid accumulation and aerobic glycolysis in the human brain. Neurobiology of Aging. 96: 165-175. PMID 33011615 DOI: 10.1016/J.Neurobiolaging.2020.08.019 |
0.546 |
|
| 2020 |
Vermunt L, Dicks E, Wang G, Dincer A, Flores S, Keefe SJ, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Fox NC, Ghetti B, Graff-Radford NR, Hassenstab J, Karch CM, ... ... Morris JC, et al. Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease. Brain Communications. 2: fcaa102. PMID 32954344 DOI: 10.1093/braincomms/fcaa102 |
0.497 |
|
| 2020 |
Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Erus G, Nasrallah I, Launer LJ, Rashid T, Bilgel M, Fan Y, Toledo JB, Yaffe K, Sotiras A, Srinivasan D, ... ... Morris JC, et al. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32920988 DOI: 10.1002/Alz.12178 |
0.423 |
|
| 2020 |
Sheline YI, Snider BJ, Beer JC, Seok D, Fagan AM, Suckow RF, Lee JM, Waligorska T, Korecka M, Aselcioglu I, Morris JC, Shaw LM, Cirrito JR. Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trial. Neurology. PMID 32913021 DOI: 10.1212/Wnl.0000000000010725 |
0.337 |
|
| 2020 |
Olive C, Ibanez L, Farias FHG, Wang F, Budde JP, Norton JB, Gentsch J, Morris JC, Li Z, Dube U, Del-Aguila J, Bergmann K, Bradley J, Benitez BA, Harari O, et al. Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes. Journal of Alzheimer's Disease : Jad. PMID 32894242 DOI: 10.3233/Jad-200019 |
0.319 |
|
| 2020 |
Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Neurology. PMID 32873693 DOI: 10.1212/Wnl.0000000000010747 |
0.459 |
|
| 2020 |
Li H, Knight WC, Yang P, Guo Y, Perlmutter JS, Morris JC, Bateman RJ, Benzinger TLS, Xu J. Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype. International Journal of Molecular Sciences. 21. PMID 32842621 DOI: 10.3390/Ijms21176047 |
0.419 |
|
| 2020 |
Gonneaud J, Bedetti C, Binette AP, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S. Association of education with Aβ burden in preclinicial familial and sporadic Alzheimer disease. Neurology. PMID 32759192 DOI: 10.1212/Wnl.0000000000010314 |
0.445 |
|
| 2020 |
Keleman A, Wisch JK, Bollinger RM, Grant EA, Benzinger TL, Morris JC, Ances BM, Stark SL. Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32741815 DOI: 10.3233/Jad-200192 |
0.487 |
|
| 2020 |
Aschenbrenner AJ, Petros J, McDade E, Wang G, Balota DA, Benzinger TL, Cruchaga C, Goate A, Xiong C, Perrin R, Fagan AM, Graff-Radford N, Ghetti B, Levin J, Weidinger E, ... ... Morris JC, et al. Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12038. PMID 32587883 DOI: 10.1002/Dad2.12038 |
0.476 |
|
| 2020 |
Schultz SA, Strain JF, Adedokun A, Wang Q, Preische O, Kuhle J, Flores S, Keefe S, Dincer A, Ances BM, Berman SB, Brickman AM, Cash DM, Chhatwal J, Cruchaga C, ... ... Morris JC, et al. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. Neurobiology of Disease. 104960. PMID 32522711 DOI: 10.1016/J.Nbd.2020.104960 |
0.515 |
|
| 2020 |
Stojanovic M, Jin Y, Fagan AM, Benzinger TL, Hassenstab J, Cruchaga C, Morris JC, Head D. Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning. Alzheimer Disease and Associated Disorders. PMID 32520736 DOI: 10.1097/Wad.0000000000000385 |
0.388 |
|
| 2020 |
Wisch JK, Meeker KL, Gordon BA, Flores S, Dincer A, Grant EA, Benzinger TL, Morris JC, Ances BM. Sex-related Differences in Tau Positron Emission Tomography (PET) and the Effects of Hormone Therapy (HT). Alzheimer Disease and Associated Disorders. PMID 32520734 DOI: 10.1097/Wad.0000000000000393 |
0.541 |
|
| 2020 |
Millar PR, Petersen SE, Ances BM, Gordon BA, Benzinger TLS, Morris JC, Balota DA. Evaluating the Sensitivity of Resting-State BOLD Variability to Age and Cognition after Controlling for Motion and Cardiovascular Influences: A Network-Based Approach. Cerebral Cortex (New York, N.Y. : 1991). PMID 32515824 DOI: 10.1093/Cercor/Bhaa138 |
0.483 |
|
| 2020 |
Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D'Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, ... ... Morris JC, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 581: 71-76. PMID 32376954 DOI: 10.1038/S41586-020-2247-3 |
0.471 |
|
| 2020 |
Koenig LN, Day GS, Salter A, Keefe S, Marple LM, Long J, LaMontagne P, Massoumazada P, Snider BJ, Kanthamneni M, Raji CA, Ghoshal N, Gordon BA, Miller-Thomas M, Morris JC, et al. Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia. Neuroimage. Clinical. 26: 102248. PMID 32334404 DOI: 10.1016/j.nicl.2020.102248 |
0.543 |
|
| 2020 |
Pichet Binette A, Vachon-Presseau É, Morris J, Bateman R, Benzinger T, Collins DL, Poirier J, Breitner JCS, Villeneuve S. Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease. Biological Psychiatry. PMID 32228870 DOI: 10.1016/J.Biopsych.2020.01.023 |
0.409 |
|
| 2020 |
Day GS, Rappai T, Sathyan S, Morris JC. Deciphering the factors that influence participation in studies requiring serial lumbar punctures. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12003. PMID 32211499 DOI: 10.1002/Dad2.12003 |
0.333 |
|
| 2020 |
Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z |
0.585 |
|
| 2020 |
Aschenbrenner AJ, Gordon BA, Fagan AM, Schindler SE, Balota DA, Morris JC, Hassenstab JJ. Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32144992 DOI: 10.3233/Jad-200018 |
0.572 |
|
| 2020 |
Babulal GM, Roe CM, Stout SH, Rajasekar G, Wisch JK, Benzinger TLS, Morris JC, Ances BM. Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal Adults. Journal of Alzheimer's Disease : Jad. PMID 32144985 DOI: 10.3233/Jad-191078 |
0.392 |
|
| 2020 |
Wisch JK, Roe CM, Babulal GM, Schindler SE, Fagan AM, Benzinger TL, Morris JC, Ances BM. Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32144983 DOI: 10.3233/Jad-191039 |
0.426 |
|
| 2020 |
Xiong C, Luo J, Coble D, Agboola F, Kukull W, Morris JC. Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32067357 DOI: 10.1002/Alz.12060 |
0.471 |
|
| 2020 |
Franzmeier N, Koutsouleris N, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Duering M, Dichgans M, Levin J, Gordon BA, Lim YY, Masters CL, Rossor M, Fox NC, ... ... Morris JC, et al. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043733 DOI: 10.1002/Alz.12032 |
0.588 |
|
| 2020 |
Levine TF, Allison SL, Stojanovic M, Fagan AM, Morris JC, Head D. Spatial navigation ability predicts progression of dementia symptomatology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043719 DOI: 10.1002/Alz.12031 |
0.379 |
|
| 2020 |
Orme T, Hernandez D, Ross OA, Kun-Rodrigues C, Darwent L, Shepherd CE, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, ... ... Morris JC, et al. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies. Acta Neuropathologica Communications. 8: 5. PMID 31996268 DOI: 10.1186/S40478-020-0879-Z |
0.421 |
|
| 2020 |
Lucey BP, McCullough A, Landsness EC, Toedebusch CD, McLeland JS, Zaza AM, Fagan AM, McCue L, Xiong C, Morris JC, Benzinger TLS, Holtzman DM. Erratum: Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease (Science Translational Medicine DOI: 10.1126/scitranslmed.aau6550) Science Translational Medicine. 12. PMID 31915302 DOI: 10.1126/Scitranslmed.Aba5187 |
0.312 |
|
| 2020 |
Aschenbrenner AJ, James BD, McDade E, Wang G, Lim YY, Benzinger TLS, Cruchaga C, Goate A, Xiong C, Perrin R, Buckles V, Allegri R, Berman SB, Chhatwal JP, Fagan A, ... ... Morris JC, et al. Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 219-228. PMID 31914221 DOI: 10.1002/Alz.12010 |
0.356 |
|
| 2019 |
Contreras JA, Aslanyan V, Sweeney MD, Sanders LMJ, Sagare AP, Zlokovic BV, Toga AW, Han SD, Morris JC, Fagan A, Massoumzadeh P, Benzinger TL, Pa J. Functional connectivity among brain regions affected in Alzheimer's disease is associated with CSF TNF-α in APOE4 carriers. Neurobiology of Aging. PMID 31870643 DOI: 10.1016/J.Neurobiolaging.2019.10.013 |
0.418 |
|
| 2019 |
Lessov-Schlaggar CN, Del Rosario OL, Morris JC, Ances BM, Schlaggar BL, Constantino JN. Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome. Journal of Neurodevelopmental Disorders. 11: 39. PMID 31842726 DOI: 10.1186/S11689-019-9300-2 |
0.395 |
|
| 2019 |
Llibre-Guerra JJ, Li Y, Schindler SE, Gordon BA, Fagan AM, Morris JC, Benzinger TLS, Hassenstab J, Wang G, Allegri R, Berman SB, Chhatwal J, Farlow MR, Holtzman DM, Jucker M, et al. Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease. Jama Network Open. 2: e1917126. PMID 31825500 DOI: 10.1001/jamanetworkopen.2019.17126 |
0.513 |
|
| 2019 |
Duchek JM, Aschenbrenner AJ, Fagan AM, Benzinger TLS, Morris JC, Balota DA. The Relation Between Personality and Biomarkers in Sensitivity and Conversion to Alzheimer-Type Dementia. Journal of the International Neuropsychological Society : Jins. 1-11. PMID 31822309 DOI: 10.1017/S1355617719001358 |
0.458 |
|
| 2019 |
Moore KM, Nicholas J, Grossman M, McMillan CT, Irwin DJ, Massimo L, Van Deerlin VM, Warren JD, Fox NC, Rossor MN, Mead S, Bocchetta M, Boeve BF, Knopman DS, Graff-Radford NR, ... ... Morris JC, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. The Lancet. Neurology. PMID 31810826 DOI: 10.1016/S1474-4422(19)30394-1 |
0.334 |
|
| 2019 |
Carr DB, Stowe JD, Morris JC. Driving in the elderly in health and disease. Handbook of Clinical Neurology. 167: 563-573. PMID 31753155 DOI: 10.1016/B978-0-12-804766-8.00031-5 |
0.378 |
|
| 2019 |
Morris GM, Holden TR, Weng H, Xiong C, Coble DW, Cairns NJ, Morris JC. Comparative Performance and Neuropathologic Validation of the AD8 Dementia Screening Instrument. Alzheimer Disease and Associated Disorders. PMID 31725472 DOI: 10.1097/Wad.0000000000000362 |
0.434 |
|
| 2019 |
Day GS, Cruchaga C, Wingo T, Schindler SE, Coble D, Morris JC. Association of Acquired and Heritable Factors With Intergenerational Differences in Age at Symptomatic Onset of Alzheimer Disease Between Offspring and Parents With Dementia. Jama Network Open. 2: e1913491. PMID 31617930 DOI: 10.1001/jamanetworkopen.2019.13491 |
0.34 |
|
| 2019 |
Li H, Yang P, Knight W, Guo Y, Perlmutter JS, Tammie BLS, Morris JC, Xu J. The Interactions of Dopamine and Oxidative Damage in the Striatum of Neurodegenerative Diseases Patients. Journal of Neurochemistry. PMID 31613384 DOI: 10.1111/Jnc.14898 |
0.346 |
|
| 2019 |
Dube U, Del-Aguila JL, Li Z, Budde JP, Jiang S, Hsu S, Ibanez L, Fernandez MV, Farias F, Norton J, Gentsch J, Wang F, Salloway S, Masters CL, ... ... Morris JC, et al. An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nature Neuroscience. PMID 31591557 DOI: 10.1038/S41593-019-0501-5 |
0.425 |
|
| 2019 |
Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, ... ... Morris JC, et al. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506247 DOI: 10.1016/J.Jalz.2019.06.4955 |
0.49 |
|
| 2019 |
Schultz SA, Gordon BA, Mishra S, Su Y, Morris JC, Ances BM, Duchek JM, Balota DA, Benzinger TLS. Association between personality and tau-PET binding in cognitively normal older adults. Brain Imaging and Behavior. PMID 31486975 DOI: 10.1007/S11682-019-00163-Y |
0.576 |
|
| 2019 |
Li Z, Farias FHG, Dube U, Del-Aguila JL, Mihindukulasuriya KA, Fernandez MV, Ibanez L, Budde JP, Wang F, Lake AM, Deming Y, Perez J, Yang C, Bahena JA, Qin W, ... ... Morris JC, et al. The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion. Acta Neuropathologica. PMID 31456032 DOI: 10.1007/S00401-019-02066-0 |
0.359 |
|
| 2019 |
Carpenter CR, McFarland F, Avidan M, Berger M, Inouye SK, Karlawish J, Lin FR, Marcantonio E, Morris JC, Reuben DB, Shah RC, Whitson HE, Asthana S, Verghese J. Impact of Cognitive Impairment Across Specialties: Summary of a Report From the U13 Conference Series. Journal of the American Geriatrics Society. PMID 31436318 DOI: 10.1111/Jgs.16093 |
0.335 |
|
| 2019 |
Xu J, Sun J, Perrin RJ, Mach RH, Bales KR, Morris JC, Benzinger TLS, Holtzman DM. Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains. Annals of Clinical and Translational Neurology. 6: 1423-1434. PMID 31402620 DOI: 10.1002/Acn3.50837 |
0.458 |
|
| 2019 |
Del-Aguila JL, Li Z, Dube U, Mihindukulasuriya KA, Budde JP, Fernandez MV, Ibanez L, Bradley J, Wang F, Bergmann K, Davenport R, Morris JC, Holtzman DM, Perrin RJ, Benitez BA, et al. A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain. Alzheimer's Research & Therapy. 11: 71. PMID 31399126 DOI: 10.1186/S13195-019-0524-X |
0.414 |
|
| 2019 |
Bos I, Vos SJB, Schindler SE, Hassenstab J, Xiong C, Grant E, Verhey F, Morris JC, Visser PJ, Fagan AM. Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31378575 DOI: 10.1016/J.Jalz.2019.04.015 |
0.463 |
|
| 2019 |
Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, Holtzman DM, Morris JC, Benzinger TLS, Xiong C, Fagan AM, Bateman RJ. High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis. Neurology. PMID 31371569 DOI: 10.1212/Wnl.0000000000008081 |
0.533 |
|
| 2019 |
Schultz A, Kloet RW, Sohrabi HR, van der Weerd L, van Rooden S, Wermer MJH, Grand Moursel L, Yaqub M, van Berckel BNM, Chatterjee P, Gardener SL, Taddei K, Fagan AM, Benzinger TL, Morris JC, et al. Amyloid Imaging of Dutch-type Hereditary Cerebral Amyloid Angiopathy Carriers. Annals of Neurology. PMID 31361916 DOI: 10.1002/Ana.25560 |
0.355 |
|
| 2019 |
Han F, Perrin RJ, Wang Q, Wang Y, Perlmutter JS, Morris JC, Benzinger TLS, Xu J. Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample Study. Parkinson's Disease. 2019: 7975407. PMID 31354934 DOI: 10.1155/2019/7975407 |
0.409 |
|
| 2019 |
Allison SL, Rodebaugh TL, Johnston C, Fagan AM, Morris JC, Head D. Developing a Spatial Navigation Screening Tool Sensitive to the Preclinical Alzheimer Disease Continuum. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 31197326 DOI: 10.1093/Arclin/Acz019 |
0.379 |
|
| 2019 |
Thirunavu V, McCullough A, Su Y, Flores S, Dincer A, Morris JC, Cruchaga C, Benzinger TLS, Gordon BA. Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life. Journal of Alzheimer's Disease : Jad. PMID 31156169 DOI: 10.3233/Jad-190154 |
0.556 |
|
| 2019 |
Del-Aguila JL, Benitez BA, Li Z, Dube U, Mihindukulasuriya KA, Budde JP, Farias FHG, Fernández MV, Ibanez L, Jiang S, Perrin RJ, Cairns NJ, Morris JC, Harari O, Cruchaga C. TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers. Molecular Neurodegeneration. 14: 18. PMID 31068200 DOI: 10.1186/S13024-019-0319-3 |
0.431 |
|
| 2019 |
Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, ... ... Morris JC, et al. Heritability and genetic variance of dementia with Lewy bodies. Neurobiology of Disease. PMID 30953760 DOI: 10.1016/J.Nbd.2019.04.004 |
0.357 |
|
| 2019 |
Wang Q, Wang Y, Liu J, Sutphen CL, Cruchaga C, Blazey T, Gordon BA, Su Y, Chen C, Shimony JS, Ances BM, Cairns NJ, Fagan AM, Morris JC, Benzinger TLS. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease. Neuroimage. Clinical. 22: 101767. PMID 30901713 DOI: 10.1016/J.Nicl.2019.101767 |
0.567 |
|
| 2019 |
Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, ... ... Morris JC, et al. The BDNF SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease. Molecular Psychiatry. PMID 30899092 DOI: 10.1038/S41380-019-0404-6 |
0.57 |
|
| 2019 |
Vöglein J, Paumier K, Jucker M, Preische O, McDade E, Hassenstab J, Benzinger TL, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, Farlow MR, Chhatwal J, Salloway S, Xiong C, ... ... Morris JC, et al. Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30897203 DOI: 10.1093/Brain/Awz050 |
0.4 |
|
| 2019 |
Su Y, Flores S, Wang G, Hornbeck RC, Speidel B, Joseph-Mathurin N, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Jack CR, Farlow MR, Salloway S, Snider BJ, Berman SB, ... ... Morris JC, et al. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 180-190. PMID 30847382 DOI: 10.1016/J.Dadm.2018.12.008 |
0.498 |
|
| 2019 |
Schindler SE, Li Y, Todd KW, Herries EM, Henson RL, Gray JD, Wang G, Graham DL, Shaw LM, Trojanowski JQ, Hassenstab JJ, Benzinger TLS, Cruchaga C, Jucker M, Levin J, ... ... Morris JC, et al. Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30846386 DOI: 10.1016/J.Jalz.2018.12.019 |
0.427 |
|
| 2019 |
Soldan A, Pettigrew C, Fagan AM, Schindler SE, Moghekar A, Fowler C, Li QX, Collins SJ, Carlsson C, Asthana S, Masters CL, Johnson S, Morris JC, Albert M, Gross AL. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology. PMID 30842300 DOI: 10.1212/Wnl.0000000000007248 |
0.333 |
|
| 2019 |
Ly CV, Koenig L, Christensen J, Gordon B, Beaumont H, Dahiya S, Chen J, Su Y, Nelson B, Jockel-Balsarotti J, Drain C, Jerome G, Morris JC, Fagan AM, Harms MB, et al. Tau positron emission tomography imaging in C9orf72 repeat expansion carriers. European Journal of Neurology. PMID 30790403 DOI: 10.1111/Ene.13940 |
0.51 |
|
| 2019 |
Wang G, Coble D, McDade EM, Hassenstab J, Fagan AM, Benzinger TLS, Bateman RJ, Morris JC, Xiong C. Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30773445 DOI: 10.1016/J.Jalz.2018.12.008 |
0.447 |
|
| 2019 |
Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, ... ... Morris JC, et al. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Brain : a Journal of Neurology. PMID 30753379 DOI: 10.1093/Brain/Awz019 |
0.602 |
|
| 2019 |
Navid J, Day GS, Strain J, Perrin RJ, Bucelli RC, Dincer A, Wisch JK, Soleimani-Meigooni D, Morris JC, Benzinger TLS, Ances BM. The Structural Signature of Sporadic Creutzfeldt-Jakob Disease. European Journal of Neurology. PMID 30735286 DOI: 10.1111/Ene.13930 |
0.393 |
|
| 2019 |
Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, ... ... Morris JC, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nature Medicine. PMID 30664784 DOI: 10.1038/S41591-018-0304-3 |
0.573 |
|
| 2019 |
Nation DA, Sweeney MD, Montagne A, Sagare AP, D'Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nature Medicine. PMID 30643288 DOI: 10.1038/S41591-018-0297-Y |
0.474 |
|
| 2019 |
Han JY, Besser LM, Xiong C, Kukull WA, Morris JC. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia. Alzheimer Disease and Associated Disorders. PMID 30633043 DOI: 10.1097/Wad.0000000000000291 |
0.463 |
|
| 2019 |
Lucey BP, McCullough A, Landsness EC, Toedebusch CD, McLeland JS, Zaza AM, Fagan AM, McCue L, Xiong C, Morris JC, Benzinger TLS, Holtzman DM. Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease. Science Translational Medicine. 11. PMID 30626715 DOI: 10.1126/Scitranslmed.Aau6550 |
0.471 |
|
| 2019 |
Morris JC, Schindler SE, McCue LM, Moulder KL, Benzinger TLS, Cruchaga C, Fagan AM, Grant E, Gordon BA, Holtzman DM, Xiong C. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease. Jama Neurology. PMID 30615028 DOI: 10.1001/Jamaneurol.2018.4249 |
0.572 |
|
| 2019 |
Sinha N, Zhou A, Li Y, Joseph-Mathurin N, Xiong C, Morris J, Bateman R, Benzinger T, Cairns N, Adrc K, Dian. Stereologic measures of beta-amyloid load in postmortem autosomal dominant Alzheimer disease brain validate PiB-PET as a useful biomarker Canadian Journal of Neurological Sciences. 46. DOI: 10.1017/Cjn.2019.257 |
0.364 |
|
| 2019 |
Chen G, Gordon BA, Liu J, LaMontagne PJ, Keefe S, Dincer A, Morris JC, Benzinger TL. P1-246: BASELINE BIOMARKERS ARE MORE ACCURATE THAN LONGITUDINAL CHANGE OF BIOMARKERS IN PREDICTING COGNITIVE DECLINE Alzheimer's & Dementia. 15: P332-P333. DOI: 10.1016/J.Jalz.2019.06.801 |
0.526 |
|
| 2019 |
Strain JF, Wisch J, Kilgore CB, McDade E, Li Y, Barthélemy NR, Gordon BA, Hassenstab J, Fagan AM, Morris JC, Benzinger TLS, Bateman R, Ances BM, Dian. Ic‐P‐098: Phosphorylation Of Specific Tau Sites Is Associated With Loss Of White Matter Integrity In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4941 |
0.57 |
|
| 2019 |
Schultz SA, Adedokun A, Strain JF, Wang Q, Preische O, Kuhle J, Morris JC, Bateman R, Jucker M, Gordon BA, Benzinger TLS. Ic-P-094: Cross-Sectional And Longitudinal Association Between Serum Neurofilament Light And Established White Matter Neuroimaging Markers In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4937 |
0.543 |
|
| 2019 |
Dincer A, Gordon BA, Vlassenko AG, Goyal MS, Aschenbrenner AJ, McCullough AA, Adedokun A, Marple LM, Flores S, Keefe S, Chen G, Hornbeck RC, Morris JC, Benzinger TL. IC-P-090: COMPARISON OF ALZHEIMER'S DISEASE BIOMARKER MEASURES AS PREDICTORS OF COGNITION Alzheimer's & Dementia. 15: P80-P80. DOI: 10.1016/J.Jalz.2019.06.4933 |
0.596 |
|
| 2019 |
Gonneaud J, Baria A, Binette AP, Benzinger TLS, Morris JC, Bateman R, Breitner JCS, Poirier J, Vachon-Presseau E, Villeneuve S. Ic-P-054: Prediction Of Brain Age Using Resting-State Functional Connectivity Reveals Accelerated Aging In The Preclinical Phase Of Autosomal Dominant Alzheimer'S Disease, Irrespectiveof Amyloid Pathology Alzheimers & Dementia. 15: 240. DOI: 10.1016/J.Jalz.2019.06.4897 |
0.366 |
|
| 2019 |
Schultz SA, Adedokun A, Strain JF, Wang Q, Preische O, Kuhle J, Morris JC, Bateman R, Jucker M, Gordon BA, Benzinger TLS. O3-12-01: Association Between Serum Neurofilament Light And Established White Matter Neuroimaging Markers In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4690 |
0.546 |
|
| 2019 |
Wang G, Aschenbrenner AJ, Li Y, Mcdade E, Liu L, Benzinger TLS, Bateman R, Morris JC, Hassenstab J, Berry S, Xiong C. Two-Period Linear Mixed Effects Primary Analysis Model For Clinical Trials With Run-In Data For Alzheimer Disease Alzheimers & Dementia. 15: 217. DOI: 10.1016/J.Jalz.2019.06.4566 |
0.314 |
|
| 2019 |
Wang G, Lorenzi M, Li Y, Donohue MC, Mcdade E, Aschenbrenner AJ, Benzinger TL, Fagan AM, Schindler SE, Hassenstab J, Berry S, Morris JC, Xiong C, Bateman R. ESTIMATING YEARS FROM CLINICAL SYMPTOM ONSET FOR SPORADIC ALZHEIMER DISEASE: HOW FAR ARE WE? Alzheimer's & Dementia. 15: P216-P217. DOI: 10.1016/J.Jalz.2019.06.4565 |
0.323 |
|
| 2019 |
Li Y, Schindler SE, Llibre Guerra JJ, Bollinger JG, Ovod V, Mawuenyega KG, Gordon BA, Holtzman DM, Morris JC, Benzinger TL, Xiong C, Fagan AM, Bateman R. PLASMA Aβ42/Aβ40 PREDICTS HIPPOCAMPAL ATROPHY Alzheimer's & Dementia. 15: P191-P192. DOI: 10.1016/J.Jalz.2019.06.4519 |
0.537 |
|
| 2019 |
Bateman R, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, Holtzman DM, Morris JC, Benzinger TL, Xiong C, Fagan AM. F2-07-01: BLOOD AMYLOID-BETA PREDICTS AMYLOID PET CONVERSION Alzheimer's & Dementia. 15: P526-P526. DOI: 10.1016/J.Jalz.2019.06.4440 |
0.509 |
|
| 2019 |
Morris JC. VALUE OF STUDY PARTNER REPORTS TO ASSESS AND PREDICT COGNITIVE IMPAIRMENT AND DECLINE Alzheimer's & Dementia. 15: P175. DOI: 10.1016/J.Jalz.2019.06.4369 |
0.306 |
|
| 2019 |
Joseph-Mathurin N, Perrin RJ, Cairns NJ, Franklin EE, Xiong C, Preboske GM, Jack CR, Morris JC, Bateman R, Benzinger TLS. Ic-P-046: Cerebral Amyloid Angiopathy Is More Severe In Autosomal Dominant Ad Cases With Cerebral Microhemorrhages: Results From The Dian Study Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4208 |
0.325 |
|
| 2019 |
Butt OH, Wisch J, Schindler SE, Fagan AM, Benzinger TL, Cruchaga C, Morris JC, Ances BM. IC-P-023: EARLY RESTING-STATE NETWORK DYSFUNCTION IN APOE
ε4 CARRIERS WITHOUT BIOMARKER EVIDENCE OF ALZHEIMER'S DISEASE IS RELATED TO SUBCLINICAL TAU CHANGES Alzheimer's & Dementia. 15: P30-P31. DOI: 10.1016/J.Jalz.2019.06.4185 |
0.388 |
|
| 2019 |
Wisch J, Roe CM, Babulal GM, Schindler SE, Fagan AM, Benzinger TL, Morris JC, Ances BM. IC-P-021: LONGITUDINAL CHANGES IN FUNCTIONAL CONNECTIVITY IN CONVERSION TO SYMPTOMATIC AD Alzheimer's & Dementia. 15: P29-P29. DOI: 10.1016/J.Jalz.2019.06.4183 |
0.316 |
|
| 2019 |
Flores S, Gordon BA, Su Y, Christensen J, Dincer A, Adedokun A, Wang Q, Hornbeck RC, Morris JC, Benzinger TL. P4-268: QUANTIFYING OFF-TARGET SKULL BINDING IN TAU PET STUDIES USING A CT-BASED MASK Alzheimer's & Dementia. 15: P1384-P1385. DOI: 10.1016/J.Jalz.2019.06.3937 |
0.489 |
|
| 2019 |
Wang Q, Dincer A, McCullough AA, Hassenstab J, Gordon BA, Liu J, Morris JC, Benzinger TLS, Wang Y. P4-261: White Matter Vasogenic Edema And Its Association With Neuropsychological Measures In Alzheimer Disease Alzheimers & Dementia. 15: 149. DOI: 10.1016/J.Jalz.2019.06.3930 |
0.582 |
|
| 2019 |
Fernandez V, Del-Aguila JL, Li Z, Dube U, Davenport R, Bradley J, Mihindukulasuriya KA, Farias FH, Budde JP, Norton J, Gentsch J, Morris JC, Harari O, Cruchaga C. P4-106: INTEGRATIVE ANALYSIS POINTS TO AGFG2
AS A NOVEL PLAYER IN THE PATHOLOGY OF ALZHEIMER DISEASE Alzheimer's & Dementia. 15: P1315-P1316. DOI: 10.1016/J.Jalz.2019.06.3767 |
0.384 |
|
| 2019 |
Rajasekar G, Roe CM, Babulal GM, Stout SH, Fagan AM, Holtzman DM, Ances BM, Morris JC. P3-591: Examining The Association Between Intraindividual Means And Standard Deviations Of Reaction Time And Preclinical Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3628 |
0.355 |
|
| 2019 |
Vlassenko AG, Gordon BA, Durbin TJ, Couture LE, Morris JC, Benzinger TL, Raichle ME, Goyal MS. P3-407: PIB BINDING TOPOGRAPHY BEST CORRELATES WITH YOUNG ADULT GLYCOLYSIS Alzheimer's & Dementia. 15: P1109-P1110. DOI: 10.1016/J.Jalz.2019.06.3441 |
0.462 |
|
| 2019 |
Ringman JM, Coppola G, Joe EB, Bateman R, Morris JC, Benzinger TL, Chui HC. P3-182: AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE ARISING FROM A NOVEL TRUNCATION MUTATION IN PSEN1 Alzheimer's & Dementia. 15: P1000-P1000. DOI: 10.1016/J.Jalz.2019.06.3211 |
0.362 |
|
| 2019 |
Luckett PH, Morris JC, Benzinger TL, Ances BM. P3-075: MODELING FUNCTIONAL CONNECTIVITY CHANGES IN LATE ONSET ALZHEIMER'S DISEASE USING DEEP LEARNING Alzheimer's & Dementia. 15: P954-P955. DOI: 10.1016/J.Jalz.2019.06.3102 |
0.345 |
|
| 2019 |
Dincer A, Mehrotra V, Aschenbrenner AJ, McCullough AA, Duchek JM, Balota DA, Chen G, Hornbeck RC, Morris JC, Benzinger TL, Gordon BA. P2-412: PRECLINICAL AD PATHOLOGY PARTIALLY MEDIATES THE RELATIONSHIP BETWEEN CORTICAL THICKNESS AND ATTENTIONAL CONTROL Alzheimer's & Dementia. 15: P765-P766. DOI: 10.1016/J.Jalz.2019.06.2819 |
0.555 |
|
| 2018 |
Vöglein J, Noachtar S, McDade E, Quaid KA, Salloway S, Ghetti B, Noble J, Berman S, Chhatwal J, Mori H, Fox N, Allegri R, Masters CL, Buckles V, Ringman JM, ... ... Morris JC, et al. Seizures as an early symptom of autosomal dominant Alzheimer's disease. Neurobiology of Aging. 76: 18-23. PMID 30616208 DOI: 10.1016/J.Neurobiolaging.2018.11.022 |
0.306 |
|
| 2018 |
Wang G, Xiong C, McDade EM, Hassenstab J, Aschenbrenner AJ, Fagan AM, Benzinger TLS, Gordon BA, Morris JC, Li Y, Bateman RJ. Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 669-676. PMID 30569014 DOI: 10.1016/J.Trci.2018.10.009 |
0.597 |
|
| 2018 |
Bussy A, Snider BJ, Coble D, Xiong C, Fagan AM, Cruchaga C, Benzinger TLS, Gordon BA, Hassenstab J, Bateman RJ, Morris JC. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. Neurobiology of Aging. 75: 42-50. PMID 30530186 DOI: 10.1016/J.Neurobiolaging.2018.10.011 |
0.587 |
|
| 2018 |
Javaherian K, Newman BM, Weng H, Hassenstab J, Xiong C, Coble D, Fagan AM, Benzinger T, Morris JC. Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease. Alzheimer Disease and Associated Disorders. PMID 30489279 DOI: 10.1097/Wad.0000000000000284 |
0.379 |
|
| 2018 |
Suárez-Calvet M, Capell A, Araque Caballero MÁ, Morenas-Rodríguez E, Fellerer K, Franzmeier N, Kleinberger G, Eren E, Deming Y, Piccio L, Karch CM, Cruchaga C, Paumier K, Bateman RJ, Fagan AM, ... Morris JC, et al. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. Embo Molecular Medicine. PMID 30482868 DOI: 10.15252/Emmm.201809712 |
0.52 |
|
| 2018 |
Twohig D, Rodriguez-Vieitez E, Sando SB, Berge G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, Patra K, Bu G, Benzinger TLS, Karch CM, Fagan A, Morris JC, Bateman RJ, et al. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Acta Neuropathologica Communications. 6: 130. PMID 30477568 DOI: 10.1186/S40478-018-0624-Z |
0.493 |
|
| 2018 |
Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, ... ... Morris JC, et al. A comprehensive screening of copy number variability in dementia with Lewy bodies. Neurobiology of Aging. PMID 30448004 DOI: 10.1016/J.Neurobiolaging.2018.10.019 |
0.344 |
|
| 2018 |
Joseph-Mathurin N, Su Y, Blazey TM, Jasielec M, Vlassenko A, Friedrichsen K, Gordon BA, Hornbeck RC, Cash L, Ances BM, Veale T, Cash DM, Brickman AM, Buckles V, Cairns NJ, ... ... Morris JC, et al. Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 669-677. PMID 30417072 DOI: 10.1016/J.Dadm.2018.08.012 |
0.513 |
|
| 2018 |
Babulal GM, Chen S, Williams MM, Trani JF, Bakhshi P, Chao GL, Stout SH, Fagan AM, Benzinger TLS, Holtzman DM, Morris JC, Roe CM. Depression and Alzheimer's Disease Biomarkers Predict Driving Decline. Journal of Alzheimer's Disease : Jad. PMID 30400098 DOI: 10.3233/Jad-180564 |
0.393 |
|
| 2018 |
Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, Jicha G, Carlsson C, Burns J, Quinn J, Sweet RA, Rascovsky K, Teylan M, Beekly D, Thomas G, ... ... Morris JC, et al. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Disease and Associated Disorders. PMID 30376508 DOI: 10.1097/Wad.0000000000000279 |
0.343 |
|
| 2018 |
Barroeta-Espar I, Weinstock LD, Perez-Nievas BG, Meltzer AC, Tick-Chong MS, Amaral AC, Murray ME, Moulder KL, Morris JC, Cairns NJ, Parisi JE, Lowe VJ, Petersen RC, Kofler J, Ikonomovic MD, et al. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology. Neurobiology of Disease. PMID 30336198 DOI: 10.1016/J.Nbd.2018.10.009 |
0.417 |
|
| 2018 |
Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ, et al. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30321505 DOI: 10.1016/J.Jalz.2018.08.005 |
0.48 |
|
| 2018 |
Roe CM, Ances BM, Head D, Babulal GM, Stout SH, Grant EA, Hassenstab J, Xiong C, Holtzman DM, Benzinger TLS, Schindler SE, Fagan AM, Morris JC. Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. Brain : a Journal of Neurology. PMID 30304397 DOI: 10.1093/Brain/Awy244 |
0.381 |
|
| 2018 |
Schultz SA, Gordon BA, Mishra S, Su Y, Perrin RJ, Cairns NJ, Morris JC, Ances BM, Benzinger TLS. Widespread distribution of tauopathy in preclinical Alzheimer's disease. Neurobiology of Aging. 72: 177-185. PMID 30292840 DOI: 10.1016/J.Neurobiolaging.2018.08.022 |
0.555 |
|
| 2018 |
Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Fox NN, Graff-Radford NR, Levin J, Danek A, ... ... Morris JC, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30266303 DOI: 10.1016/J.Jalz.2018.06.3059 |
0.472 |
|
| 2018 |
Gangishetti U, Christina Howell J, Perrin RJ, Louneva N, Watts KD, Kollhoff A, Grossman M, Wolk DA, Shaw LM, Morris JC, Trojanowski JQ, Fagan AM, Arnold SE, Hu WT. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98. PMID 30253800 DOI: 10.1186/S13195-018-0426-3 |
0.49 |
|
| 2018 |
Ihara R, Vincent BD, Baxter MR, Franklin EE, Hassenstab JJ, Xiong C, Morris JC, Cairns NJ. Relative neuron loss in hippocampal sclerosis of aging and Alzheimer disease. Annals of Neurology. PMID 30246887 DOI: 10.1002/Ana.25344 |
0.34 |
|
| 2018 |
Araque Caballero MÁ, Suárez-Calvet M, Duering M, Franzmeier N, Benzinger T, Fagan AM, Bateman RJ, Jack CR, Levin J, Dichgans M, Jucker M, Karch C, Masters CL, Morris JC, Weiner M, et al. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 30239611 DOI: 10.1093/Brain/Awy229 |
0.408 |
|
| 2018 |
Day GS, Musiek ES, Morris JC. Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions. Alzheimer Disease and Associated Disorders. PMID 30222606 DOI: 10.1097/Wad.0000000000000276 |
0.349 |
|
| 2018 |
McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. PMID 30217935 DOI: 10.1212/Wnl.0000000000006277 |
0.59 |
|
| 2018 |
Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. PMID 30068637 DOI: 10.1212/Wnl.0000000000006075 |
0.562 |
|
| 2018 |
Karch CM, Hernández D, Wang JC, Marsh J, Hewitt AW, Hsu S, Norton J, Levitch D, Donahue T, Sigurdson W, Ghetti B, Farlow M, Chhatwal J, Berman S, Cruchaga C, ... Morris JC, et al. Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network. Alzheimer's Research & Therapy. 10: 69. PMID 30045758 DOI: 10.1186/S13195-018-0400-0 |
0.391 |
|
| 2018 |
Su Y, Flores S, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Xiong C, Morris JC, Benzinger TLS. Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage. Clinical. 19: 406-416. PMID 30035025 DOI: 10.1016/J.Nicl.2018.04.022 |
0.5 |
|
| 2018 |
Hsu S, Gordon BA, Hornbeck R, Norton JB, Levitch D, Louden A, Ziegemeier E, Laforce R, Chhatwal J, Day GS, McDade E, Morris JC, Fagan AM, Benzinger TLS, Goate AM, et al. Discovery and validation of autosomal dominant Alzheimer's disease mutations. Alzheimer's Research & Therapy. 10: 67. PMID 30021643 DOI: 10.1186/S13195-018-0392-9 |
0.594 |
|
| 2018 |
Lim YY, Hassenstab J, Goate A, Fagan AM, Benzinger TLS, Cruchaga C, McDade E, Chhatwal J, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, Salloway S, Schofield P, ... Morris JC, et al. Effect of BDNFVal66Met on disease markers in dominantly inherited AD. Annals of Neurology. PMID 30014553 DOI: 10.1002/Ana.25299 |
0.46 |
|
| 2018 |
Strain JF, Smith RX, Beaumont H, Roe CM, Gordon BA, Mishra S, Adeyemo B, Christensen JJ, Su Y, Morris JC, Benzinger TLS, Ances BM. Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions. Neurology. PMID 29959265 DOI: 10.1212/Wnl.0000000000005864 |
0.578 |
|
| 2018 |
Li Z, Del-Aguila JL, Dube U, Budde J, Martinez R, Black K, Xiao Q, Cairns NJ, Dougherty JD, Lee JM, Morris JC, Bateman RJ, Karch CM, Cruchaga C, et al. Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure. Genome Medicine. 10: 43. PMID 29880032 DOI: 10.1186/S13073-018-0551-4 |
0.431 |
|
| 2018 |
Roe CM, Babulal GM, Stout SH, Ott BR, Carr DB, Williams MM, Benzinger TLS, Fagan AM, Holtzman DM, Ances BM, Morris JC. Using the A/T/N Framework to Examine Driving in Preclinical AD. Geriatrics (Basel, Switzerland). 3. PMID 29805967 DOI: 10.3390/Geriatrics3020023 |
0.452 |
|
| 2018 |
Gordon BA, McCullough A, Mishra S, Blazey TM, Su Y, Christensen J, Dincer A, Jackson K, Hornbeck RC, Morris JC, Ances BM, Benzinger TLS. Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 245-252. PMID 29780869 DOI: 10.1016/J.Dadm.2018.02.003 |
0.572 |
|
| 2018 |
Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Morris JC, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. Plos One. 13: e0195838. PMID 29742105 DOI: 10.1371/Journal.Pone.0195838 |
0.462 |
|
| 2018 |
Mishra S, Blazey TM, Holtzman DM, Cruchaga C, Su Y, Morris JC, Benzinger TLS, Gordon BA. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ɛ4 genotype. Brain : a Journal of Neurology. PMID 29672664 DOI: 10.1093/Brain/Awy103 |
0.56 |
|
| 2018 |
Vlassenko AG, Gordon BA, Goyal MS, Su Y, Blazey TM, Durbin TJ, Couture LE, Christensen JJ, Jafri H, Morris JC, Raichle ME, Benzinger TL. Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiology of Aging. 67: 95-98. PMID 29655050 DOI: 10.1016/J.Neurobiolaging.2018.03.014 |
0.555 |
|
| 2018 |
Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, ... ... Morris JC, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/J.Jalz.2018.02.009 |
0.448 |
|
| 2018 |
Oxtoby NP, Young AL, Cash DM, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ, Fox NC, Schott JM, Alexander DC. Data-driven models of dominantly-inherited Alzheimer's disease progression. Brain : a Journal of Neurology. PMID 29579160 DOI: 10.1093/Brain/Awy050 |
0.426 |
|
| 2018 |
Allison S, Babulal GM, Stout SH, Barco PP, Carr DB, Fagan AM, Morris JC, Roe CM, Head D. Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities. Alzheimer Disease and Associated Disorders. PMID 29578861 DOI: 10.1097/Wad.0000000000000257 |
0.416 |
|
| 2018 |
Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, ... ... Morris JC, et al. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain : a Journal of Neurology. PMID 29522171 DOI: 10.1093/Brain/Awy053 |
0.441 |
|
| 2018 |
Schindler SE, Gray JD, Gordon BA, Xiong C, Batrla-Utermann R, Quan M, Wahl S, Benzinger TLS, Holtzman DM, Morris JC, Fagan AM. Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29501462 DOI: 10.1016/J.Jalz.2018.01.013 |
0.56 |
|
| 2018 |
Villeneuve S, Vogel JW, Gonneaud J, Pichet Binette A, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS, Johnson SC, Breitner JCS, Poirier J. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease. Jama Neurology. PMID 29482212 DOI: 10.1001/Jamaneurol.2017.5135 |
0.431 |
|
| 2018 |
Del-Aguila JL, Fernández MV, Schindler S, Ibanez L, Deming Y, Ma S, Saef B, Black K, Budde J, Norton J, Chasse R, Harari O, Goate A, Xiong C, ... Morris JC, et al. Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline. Journal of Alzheimer's Disease : Jad. 62: 745-756. PMID 29480181 DOI: 10.3233/Jad-170834 |
0.448 |
|
| 2018 |
Franzmeier N, Düzel E, Jessen F, Buerger K, Levin J, Duering M, Dichgans M, Haass C, Suárez-Calvet M, Fagan AM, Paumier K, Benzinger T, Masters CL, Morris JC, Perneczky R, et al. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease. Brain : a Journal of Neurology. PMID 29462334 DOI: 10.1093/Brain/Awy008 |
0.467 |
|
| 2018 |
Day GS, Gordon BA, Perrin RJ, Cairns NJ, Beaumont H, Schwetye K, Ferguson C, Sinha N, Bucelli R, Musiek ES, Ghoshal N, Ponisio MR, Vincent B, Mishra S, Jackson K, ... Morris JC, et al. In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease. Neurology. PMID 29438042 DOI: 10.1212/Wnl.0000000000005064 |
0.53 |
|
| 2018 |
Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Marcus DS, Fagan AM, Jack CR, ... ... Morris JC, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. The Lancet. Neurology. PMID 29397305 DOI: 10.1016/S1474-4422(18)30028-0 |
0.584 |
|
| 2018 |
Musiek ES, Bhimasani M, Zangrilli MA, Morris JC, Holtzman DM, Ju YS. Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease. Jama Neurology. PMID 29379963 DOI: 10.1001/Jamaneurol.2017.4719 |
0.435 |
|
| 2018 |
Gabel M, Gooblar J, Roe CM, Selsor NJ, Morris JC. Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies. Alzheimer Disease and Associated Disorders. PMID 29351092 DOI: 10.1097/Wad.0000000000000244 |
0.413 |
|
| 2018 |
Stout SH, Babulal GM, Ma C, Carr DB, Head DM, Grant EA, Williams MM, Holtzman DM, Fagan AM, Morris JC, Roe CM. Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29328928 DOI: 10.1016/J.Jalz.2017.11.011 |
0.43 |
|
| 2018 |
Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, ... ... Morris JC, et al. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. The Lancet. Neurology. 17: 64-74. PMID 29263008 DOI: 10.1016/S1474-4422(17)30400-3 |
0.376 |
|
| 2018 |
Lewczuk P, Matzen A, Blennow K, Parnetti L, Molinuevo JL, Eusebi P, Kornhuber J, Morris JC, Fagan AM. Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 55: 813-822. PMID 27792012 DOI: 10.3233/Jad-160722 |
0.469 |
|
| 2018 |
Fernandez MV, Budde JP, Del-Aguila JL, Ibanez L, Deming Y, Harari O, Li Z, Dube U, Norton J, Morris JC, Goate AM, Cruchaga C, Nia-Load, Ncrad. P2-105: Nomination Of Novel Candidate Genes For Familial Late Onset Alzheimer Disease After Evaluation Of Gene-Based Family-Based Methods Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.791 |
0.304 |
|
| 2018 |
Vöglein J, Paumier KL, Cairns NJ, Franklin EE, Perrin RJ, Xiong C, Jucker M, Bateman RJ, Danek A, Morris JC, Levin J. P1-497: Clinical Correlates Of Lewy Body Pathology In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.507 |
0.381 |
|
| 2018 |
Koenig LN, Keefe S, Marple LM, Blazey T, Gordon BA, Hassenstab J, Morris JC, Miller-Thomas M, Shimony JS, Benzinger TLS. P1-390: Volumetric-Based Diagnosis Of Alzheimer'S Disease Using A Super-Normal Cohort Of Aging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.398 |
0.57 |
|
| 2018 |
Gray JD, Sutphen CL, Henson RL, Orusakwe A, Traynham C, Vandijck M, Gailey R, Lawson J, Gordon BA, Benzinger TLS, Morris JC, Fagan AM. P1-290: Concordance Between In Vivo Amyloid Imaging And Csf Ab1-42 And Total Tau Measured By The Automated Lumipulse® G Assay Platform Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.296 |
0.532 |
|
| 2018 |
Caballero MAA, Park DC, Song Z, Levin J, Bateman RJ, Morris JC, Jucker M, Danek A, Yakushev I, Benzinger TLS, Ewers M, Dian. O4-04-05: Fiber-Tract-Specific Decline In White-Matter Integrity During The Adult Lifespan And Preclinical Alzheimer'S Disease: Results From The Dallas Lifespan Brain Study And Dian Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2931 |
0.315 |
|
| 2018 |
McDade E, Li Y, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Fagan AM, Goate AM, Morris JC, Cash DM, Fox NC, Xiong C, Holtzman DM, Bateman RJ. O2-04-03: What Goes Up Must Come Down: Longitudinal Decline In Cerebrospinal Fluid Tau Peptides Is Associated With Progressive Cortical Atrophy Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2659 |
0.506 |
|
| 2018 |
Morris JC, Weiner M, Beckett L, Buckles VD, Xiong C, Dian. O2-04-01: Comparing Biomarker Rates Of Change In Autosomal Dominant Versus Sporadic Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2657 |
0.348 |
|
| 2018 |
Hassenstab J, Aschenbrenner AJ, Balota DA, McDade E, Lim Y, Fagan AM, Benzinger TLS, Cruchaga C, Goate A, Morris JC, Bateman RJ. O1-04-03: Comparing Smartphone-Administered Cognitive Assessments With Conventional Tests And Biomarkers In Sporadic And Dominantly Inherited Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2350 |
0.358 |
|
| 2018 |
Gordon BA, Blazey T, Christensen J, Flores S, Dincer A, Keefe S, McDade E, Wang G, Raichle ME, Koeppe B, Jack CR, Morris JC, Bateman RJ, Benzinger TLS. The Relationship Between Tau Pet And Other Ad Biomarkers In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2271 |
0.64 |
|
| 2018 |
Wang Q, Wang Y, Shimony JS, Liu J, Fagan AM, Cairns NJ, Ances BM, Morris JC, Benzinger TLS. Ic-P-195: Quantification Of White Matter Cellularity In Preclinical And Early Symptomatic Alzheimer Disease Using Neuro-Immnue Imaging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2262 |
0.357 |
|
| 2018 |
Molteni E, Veale T, Altmann A, Cardoso MJ, Benzinger TLS, Jack CR, McDade E, Morris JC, Rossor MN, Ourselin S, Fox NC, Cash DM, Modat M. Ic-P-165: Robust Identification Of Brain Structures Most Discriminative In Detecting Early Changes In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2232 |
0.351 |
|
| 2018 |
Gonneaud J, Bedetti C, Binette AP, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S. IC-P-158: GENETIC AND ENVIRONMENTAL FACTORS ARE DIFFERENTIALLY RELATED TO Aβ BURDEN IN THE PRESYMPTOMATIC PHASE OF AUTOSOMAL DOMINANT AND SPORADIC ALZHEIMER'S DISEASE Alzheimers & Dementia. 14: 134. DOI: 10.1016/J.Jalz.2018.06.2225 |
0.362 |
|
| 2018 |
Franzmeier N, Ren J, Bateman RJ, Morris JC, Levin J, Yakushev I, Jucker M, Benzinger TLS, Ewers M, Investigators D. F5-05-03: The Bdnf Val66Met Snp Is Related To Hippocampal Connectivity And Cognitive Decline In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2132 |
0.353 |
|
| 2018 |
Strain JF, Tanenbaum A, Smith RX, Fagan AM, Gordon BA, Hassenstab J, Xiong C, McDade E, Chhatwal JP, Morris JC, Benzinger TLS, Bateman RJ, Ances BM, Dian. Ic-P-043: Functional Architectural Differences Between Autosomal Dominant Alzheimer'S Disease And Late Onset Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2107 |
0.603 |
|
| 2018 |
Smith RX, Tanenbaum A, Strain JF, Gordon BA, Fagan AM, Hassenstab J, McDade E, Xiong C, Chhatwal JP, Morris JC, Benzinger TLS, Bateman RJ, Ances BM. P4-108: Resting-State Functional Connectivity Is Associated With Pathological Biomarkers In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2106 |
0.576 |
|
| 2018 |
Flores S, Su Y, Wang G, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, Mintun MA, Koeppe RA, Klunk WE, Xiong C, Morris JC, Bateman RJ, Benzinger TLS. Ic-P-009: Comparing The Centiloid Scale For Pittsburgh Compound B And Florbetapir In Longitudinal Pet Studies Of Sporadic Ad Alzheimers & Dementia. 14: 19. DOI: 10.1016/J.Jalz.2018.06.2073 |
0.529 |
|
| 2018 |
Schultz SA, Apel A, Preische O, Kuhle J, Gordon BA, Wang G, McDade E, Bateman RJ, Morris JC, Benzinger TLS, Jucker M. Ic-04-02: Serum Neurofilament Light Chain Levels Are Associated With Cortical Thickness, Beta-Amyloid Burden, And Cerebral Glucose Metabolism In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2050 |
0.543 |
|
| 2018 |
Franzmeier N, Ren J, Bateman RJ, Morris JC, Levin J, Jucker M, Benzinger TLS, Yakushev I, Koutsouleris N, Ewers M, Investigators D. Ic-P-090: Cross-Validated Biomarker-Based Prediction Of 4-Year Rate Of Cognitive Decline In Non-Demented Subjects At Risk Of Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1789 |
0.332 |
|
| 2018 |
Babulal GM, Chen S, Williams MM, Trani J, Bakhshi P, Chao LG, Stout SH, Fagan AM, Benzinger TLS, Holtzman DM, Morris JC, Ances BM, Roe CM. P3-319: Depression And Alzheimer Disease Biomarkers Predict Driving Decline Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1680 |
0.342 |
|
| 2018 |
Preische O, Schultz SA, Apel A, Kuhle J, Gordon BA, Wang G, McDade E, Bateman RJ, Morris JC, Benzinger TLS, Jucker M. P3-251: Serum Neurofilament Light Chain Levels Are Associated With Csf Neurofilament Light Chain, Cognitive Status, And Disease Progression In Autosomal Dominant Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1611 |
0.53 |
|
| 2018 |
Aschenbrenner AJ, Hassenstab J, Wang G, McDade E, Balota DA, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ. P2-499: Alzheimer Disease Biomarkers Predict Differences In Personality: A Cross-Lagged Panel Analysis Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1192 |
0.365 |
|
| 2018 |
Strain JF, Smith RX, Wang Q, Fagan AM, Gordon BA, Hassenstab J, Xiong C, McDade E, Morris JC, Benzinger TLS, Bateman RJ, Ances BM, Dian. P2-464: Biological Correlates Of White Matter Changes In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1157 |
0.58 |
|
| 2018 |
Barthélemy NR, Li Y, Wang G, Fagan AM, Morris JC, Benzinger TLS, Goate A, Hassenstab J, Xiong C, Sato C, Bateman RJ, McDade E. P1-023: Mass Spectrometry-Based Measurement Of Longitudinal Csf Tau Identifies Different Phosphorylated Sites That Track Distinct Stages Of Presymptomatic Dominantly Inherited Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.024 |
0.325 |
|
| 2017 |
Weintraub S, Besser L, Dodge HH, Teylan M, Ferris S, Goldstein FC, Giordani B, Kramer J, Loewenstein D, Marson D, Mungas D, Salmon D, Welsh-Bohmer K, Zhou XH, Shirk SD, ... ... Morris JC, et al. Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Disease and Associated Disorders. PMID 29240561 DOI: 10.1097/Wad.0000000000000223 |
0.442 |
|
| 2017 |
Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Morris JC, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391 |
0.46 |
|
| 2017 |
Xiong C, Luo J, Chen L, Gao F, Liu J, Wang G, Bateman R, Morris JC. Estimating diagnostic accuracy for clustered ordinal diagnostic groups in the three-class case-Application to the early diagnosis of Alzheimer disease. Statistical Methods in Medical Research. 962280217742539. PMID 29182052 DOI: 10.1177/0962280217742539 |
0.329 |
|
| 2017 |
Roe CM, Babulal GM, Mishra S, Gordon BA, Stout SH, Ott BR, Carr DB, Ances BM, Morris JC, Benzinger TLS. Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29171997 DOI: 10.3233/Jad-170521 |
0.582 |
|
| 2017 |
Fernández MV, Kim JH, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U, Harari O, Norton J, Chasse R, Morris JC, Goate A, et al. Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease. Plos Genetics. 13: e1007045. PMID 29091718 DOI: 10.1371/Journal.Pgen.1007045 |
0.438 |
|
| 2017 |
Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, Gallardo G, Wang K, Roh J, Robinson G, Finn MB, ... ... Morris JC, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 549: 523-527. PMID 28959956 DOI: 10.1038/Nature24016 |
0.365 |
|
| 2017 |
Cruchaga C, Del-Aguila JL, Saef B, Black K, Fernandez MV, Budde J, Ibanez L, Kapoor M, Tosto G, Mayeux RP, Holtzman DM, Fagan AM, Morris JC, Bateman RJ, Goate AM, et al. Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28943286 DOI: 10.1016/J.Jalz.2017.08.013 |
0.444 |
|
| 2017 |
Moulder KL, Besser LM, Beekly D, Blennow K, Kukull W, Morris JC. Factors Influencing Successful Lumbar Puncture in Alzheimer Research. Alzheimer Disease and Associated Disorders. PMID 28891819 DOI: 10.1097/Wad.0000000000000209 |
0.353 |
|
| 2017 |
Nguyen TV, Barry ME, Turner MA, Crosby CM, Trujillo MA, Morris JC, Barry MA. Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5. Biomedicines. 5. PMID 28796161 DOI: 10.3390/Biomedicines5030046 |
0.326 |
|
| 2017 |
Aisen PS, Cummings J, Jack CR, Morris JC, Sperling R, Frölich L, Jones RW, Dowsett SA, Matthews BR, Raskin J, Scheltens P, Dubois B. On the path to 2025: understanding the Alzheimer's disease continuum. Alzheimer's Research & Therapy. 9: 60. PMID 28793924 DOI: 10.1186/S13195-017-0283-5 |
0.467 |
|
| 2017 |
Ringman JM, Casado M, Van Berlo V, Pa J, Joseph-Mathurin N, Fagan AM, Benzinger T, Bateman RJ, Morris JC. A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism. Neuroscience Letters. 657: 11-15. PMID 28764909 DOI: 10.1016/J.Neulet.2017.07.046 |
0.41 |
|
| 2017 |
Mishra S, Gordon BA, Su Y, Christensen J, Friedrichsen K, Jackson K, Hornbeck R, Balota DA, Cairns NJ, Morris JC, Ances BM, Benzinger TLS. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure. Neuroimage. PMID 28756238 DOI: 10.1016/J.Neuroimage.2017.07.050 |
0.584 |
|
| 2017 |
Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, Leung KK, Cardoso MJ, Modat M, Malone IB, Morris JC, Bateman RJ, Marcus DS, Goate A, Salloway S, et al. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28738187 DOI: 10.1016/J.Jalz.2017.06.2268 |
0.386 |
|
| 2017 |
Ovod V, Ramsey KN, Mawuenyega KG, Bollinger JG, Hicks T, Schneider T, Sullivan M, Paumier K, Holtzman DM, Morris JC, Benzinger T, Fagan AM, Patterson BW, Bateman RJ. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28734653 DOI: 10.1016/J.Jalz.2017.06.2266 |
0.306 |
|
| 2017 |
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Morris J, ... ... Morris JC, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916 |
0.369 |
|
| 2017 |
Schindler SE, Sutphen CL, Teunissen C, McCue LM, Morris JC, Holtzman DM, Mulder SD, Scheltens P, Xiong C, Fagan AM. Upward drift in cerebrospinal fluid amyloid-β 42 assay values for more than 10 years. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28710906 DOI: 10.1016/J.Jalz.2017.06.2264 |
0.369 |
|
| 2017 |
Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS. A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 147-155. PMID 28653035 DOI: 10.1016/J.Dadm.2017.05.003 |
0.422 |
|
| 2017 |
Brown BM, Sohrabi HR, Taddei K, Gardener SL, Rainey-Smith SR, Peiffer JJ, Xiong C, Fagan AM, Benzinger T, Buckles V, Erickson KI, Clarnette R, Shah T, Masters CL, Weiner M, ... ... Morris JC, et al. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28501451 DOI: 10.1016/J.Jalz.2017.03.008 |
0.383 |
|
| 2017 |
Schindler SE, Jasielec MS, Weng H, Hassenstab JJ, Grober E, McCue LM, Morris JC, Holtzman DM, Xiong C, Fagan AM. Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease. Neurobiology of Aging. 56: 25-32. PMID 28482211 DOI: 10.1016/J.Neurobiolaging.2017.04.004 |
0.385 |
|
| 2017 |
Lucey BP, Fagan AM, Holtzman DM, Morris JC, Bateman RJ. Diurnal oscillation of CSF Aβ and other AD biomarkers. Molecular Neurodegeneration. 12: 36. PMID 28478762 DOI: 10.1186/S13024-017-0161-4 |
0.461 |
|
| 2017 |
Babulal GM, Stout SH, Head D, Holtzman DM, Fagan AM, Morris JC, Roe CM. Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report. Journal of Alzheimer's Disease : Jad. PMID 28453487 DOI: 10.3233/Jad-170067 |
0.446 |
|
| 2017 |
Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, ... ... Morris JC, et al. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Scientific Reports. 7: 1225. PMID 28450713 DOI: 10.1038/S41598-017-01327-W |
0.367 |
|
| 2017 |
Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, Garland B, Barco PP, Williams MM, Johnson A, Fierberg R, Fague MS, Xiong C, Mormino E, Grant EA, ... ... Morris JC, et al. Preclinical Alzheimer's disease and longitudinal driving decline. Alzheimer's & Dementia (New York, N. Y.). 3: 74-82. PMID 28435853 DOI: 10.1016/J.Trci.2016.11.006 |
0.438 |
|
| 2017 |
Day GS, Gordon BA, Jackson K, Christensen JJ, Rosana Ponisio M, Su Y, Ances BM, Benzinger TL, Morris JC. Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia. Alzheimer Disease and Associated Disorders. PMID 28394771 DOI: 10.1097/Wad.0000000000000196 |
0.584 |
|
| 2017 |
Babulal GM, Stout SH, Benzinger TL, Ott BR, Carr DB, Webb M, Traub CM, Addison A, Morris JC, Warren DK, Roe CM. A Naturalistic Study of Driving Behavior in Older Adults and Preclinical Alzheimer Disease. Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society. 733464817690679. PMID 28380718 DOI: 10.1177/0733464817690679 |
0.414 |
|
| 2017 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ, et al. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28342697 DOI: 10.1016/J.Jalz.2016.11.007 |
0.378 |
|
| 2017 |
Deming Y, Li Z, Kapoor M, Harari O, Del-Aguila JL, Black K, Carrell D, Cai Y, Fernandez MV, Budde J, Ma S, Saef B, Howells B, Huang KL, Bertelsen S, ... ... Morris JC, et al. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers. Acta Neuropathologica. PMID 28247064 DOI: 10.1007/s00401-017-1685-y |
0.311 |
|
| 2017 |
Day GS, Lim TS, Hassenstab J, Goate AM, Grant EA, Roe CM, Cairns NJ, Morris JC. Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease. Neurology. PMID 28235814 DOI: 10.1212/Wnl.0000000000003770 |
0.469 |
|
| 2017 |
Millar PR, Balota DA, Maddox GB, Duchek JM, Aschenbrenner AJ, Fagan AM, Benzinger TL, Morris JC. Process Dissociation Analyses of Memory Changes in Healthy Aging, Preclinical, and Very Mild Alzheimer Disease: Evidence for Isolated Recollection Deficits. Neuropsychology. PMID 28206782 DOI: 10.1037/Neu0000352 |
0.443 |
|
| 2017 |
Gangishetti U, Perrin RJ, Arnold SE, Fagan AM, Morris JC, Trojanowski JQ, Hu WT. VALIDATING NON-AMYLOID, NON-TAU CSF BIOMARKERS FOR ALZHEIMER'S DISEASE IN THE PRE-SYMPTOMATIC, MCI, AND DEMENTIA STAGES: A MULTI-CENTER STUDY Alzheimer's & Dementia. 13: P1513-P1514. DOI: 10.1016/J.Jalz.2017.07.632 |
0.422 |
|
| 2017 |
Bos I, Vos SJ, Hassenstab J, Xiong C, Grant EA, Visser PJ, Morris JC, Fagan AM. ASSOCIATIONS BETWEEN VASCULAR RISK FACTORS AND AD BIOMARKERS IN COGNITIVELY NORMAL INDIVIDUALS Alzheimer's & Dementia. 13: P1506-P1507. DOI: 10.1016/J.Jalz.2017.07.621 |
0.323 |
|
| 2017 |
Xiong C, McCue L, Grant EA, Bateman RJ, Fagan AM, Benzinger TL, Hassenstab J, Buckles V, Moulder KL, Paumier KL, Morris JC. CROSS-SECTIONAL AND LONGITUDINAL COMPARISONS OF COGNITION AND BIOMARKERS AMONG COGNITIVELY NORMAL INDIVIDUALS AGED 42 TO 65 YEARS WITH A FAMILY HISTORY OF EITHER AUTOSOMAL DOMINANT AD (ADAD) OR LATE-ONSET AD (LOAD) Alzheimer's & Dementia. 13: P923. DOI: 10.1016/J.Jalz.2017.07.357 |
0.34 |
|
| 2017 |
Aschenbrenner AJ, Hassenstab J, Gordon BA, Benzinger TL, Morris JC. NEUROIMAGING BIOMARKERS OF THE A/T/N CLASSIFICATION SYSTEM PREDICT CROSS-SECTIONAL AND LONGITUDINAL CHANGE IN PRECLINICAL AND EARLY ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P911. DOI: 10.1016/J.Jalz.2017.07.332 |
0.527 |
|
| 2017 |
McDade E, Wang G, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Hassenstab J, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier KL, Xiong C, Ricardo A, et al. LONGITUDINAL BIOMARKER CHANGES IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE FROM THE DIAN STUDY Alzheimer's & Dementia. 13: P879-P880. DOI: 10.1016/J.Jalz.2017.07.265 |
0.581 |
|
| 2017 |
Cairns NJ, Perrin RJ, Vincent BD, Baxter MR, Franklin EE, Bateman RJ, Morris JC. NEUROPATHOLOGIC HETEROGENEITY IN FAMILIAL AND LATE-ONSET ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P877. DOI: 10.1016/J.Jalz.2017.07.255 |
0.378 |
|
| 2017 |
Fagan AM, Schindler SE, Gray JD, Gordon BA, Xiong C, Batrla-Utermann R, Quan M, Wahl S, Buckles VD, Benzinger TL, Morris JC. CONCORDANCE BETWEEN CSF AD BIOMARKERS MEASURED BY THE AUTOMATED ELECSYS ASSAY AND IN VIVO AMYLOID IMAGING Alzheimer's & Dementia. 13: P561. DOI: 10.1016/J.Jalz.2017.07.169 |
0.545 |
|
| 2017 |
Morris JC, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Grant EA, McCue L, Moulder KL, Schindler SE, Xiong C. RACIAL DIFFERENCES AND SIMILARITIES IN MOLECULAR BIOMARKERS FOR AD Alzheimer's & Dementia. 13: P560-P561. DOI: 10.1016/J.Jalz.2017.07.168 |
0.532 |
|
| 2017 |
Roe CM, Babulal GM, Stout SH, Fagan AM, Benzinger TLS, Holtzman DM, Ott BR, Carr DB, Xiong C, Morris JC. Impact Of Cognitive Reserve And Preclinical Ad On Longitudinal Driving Performance Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.147 |
0.328 |
|
| 2017 |
Deming Y, Kapoor M, Li Z, Harari O, Black K, Del-Aguila JL, Carrell D, Cai Y, Fernandez MV, Budde JP, Ma S, Saef B, Howells B, Huang K, Bertelsen S, ... ... Morris JC, et al. CEREBROSPINAL FLUID ENDOPHENOTYPES PROVIDE INSIGHT INTO BIOLOGY UNDERLYING ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P218-P219. DOI: 10.1016/J.Jalz.2017.07.096 |
0.377 |
|
| 2017 |
Hanseeuw BJ, McDade E, Schultz AP, Martins RN, Schofield PR, Masters CL, Graff-Radford NR, Salloway S, Danek A, Levin J, Buckles V, Goate AM, Benzinger TL, Morris JC, Bateman RJ, et al. GENOTYPIC VARIANCE MAY EXPLAIN THE BALANCE OF EARLY CORTICAL VERSUS STRIATAL AMYLOID DEPOSITION IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P187-P188. DOI: 10.1016/J.Jalz.2017.07.043 |
0.337 |
|
| 2017 |
Xiong C, Wang G, Coble D, Fague S, Fagan AM, Benzinger TL, Hassenstab J, Buckles V, Moulder KL, Paumier KL, Morris JC, Bateman RJ. [P2-209]: QUANTIFYING PRECLINICAL STAGES OF AUTOSOMAL DOMINANT ALZHEIMER DISEASE (ADAD) AND THE ASSOCIATED OVERALL BIOMARKER SIGNATURE ACROSS MODALITIES USING THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN) Alzheimer's & Dementia. 13: P689-P690. DOI: 10.1016/J.Jalz.2017.06.861 |
0.402 |
|
| 2017 |
Mishra S, Gordon BA, Blazey T, Su Y, Christensen J, Jackson K, Hornbeck RC, Morris JC, Ances BM, Benzinger TL. RELATIONSHIP BETWEEN TAU POSITRON EMISSION TOMOGRAPHY WITH [18F]-AV-1451 AND LONGITUDINAL CORTICAL ATROPHY IN ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P233-P234. DOI: 10.1016/J.Jalz.2017.06.2627 |
0.549 |
|
| 2017 |
Vlassenko AG, Gordon BA, Goyal MS, Su Y, Jackson K, Durbin TJ, Couture LE, Morris JC, Benzinger TL, Raichle ME. BRAIN AEROBIC GLYCOLYSIS AND TAU DEPOSITION WITH [18F]-AV-1451 PET Alzheimer's & Dementia. 13: P922. DOI: 10.1016/J.Jalz.2017.06.2581 |
0.491 |
|
| 2017 |
Schultz SA, Gordon BA, Mishra S, Morris JC, Duchek JM, Balota DA, Benzinger TL, Ances B. THE ASSOCIATION BETWEEN PERSONALITY AND TAU PET DEPOSITION IN COGNITIVELY NORMAL OLDER ADULTS: FINDINGS FROM THE KNIGHT ALZHEIMER DISEASE RESEARCH CENTER Alzheimer's & Dementia. 13: P145-P146. DOI: 10.1016/J.Jalz.2017.06.2572 |
0.552 |
|
| 2017 |
Day GS, Gordon BA, Perrin RJ, Cairns NJ, Schwetye KE, Ferguson CJ, Sinha N, Ponisio MR, Vincent BD, Beaumont H, Bucelli RC, Ghoshal N, Musiek ES, Morris JC, Benzinger TL, et al. FLORTAUCIPIR TAU-PET SPECIFICITY IS MAINTAINED IN PATIENTS WITH PATHOLOGICALLY CONFIRMED CREUTZFELDT-JAKOB DISEASE Alzheimer's & Dementia. 13: P900-P901. DOI: 10.1016/J.Jalz.2017.06.2555 |
0.555 |
|
| 2017 |
Yablonskiy DA, Zhao Y, Cairns NJ, Hassenstab J, Benzinger TL, Astafiev SV, Wen J, Raichle ME, Morris JC. [IC-P-169]: GRADIENT ECHO PLURAL CONTRAST MRI PROVIDES NEW SURROGATE MARKERS OF BRAIN PATHOLOGY IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P127-P128. DOI: 10.1016/J.Jalz.2017.06.2544 |
0.373 |
|
| 2017 |
Hari-Raj A, Dincer A, Gordon BA, Su Y, Ances BM, Morris JC, Bateman RJ, Benzinger TL. CORTICAL THINNING PATTERN IN AUTOSOMAL DOMINANT AD PREDICTS AMYLOID POSITIVITY IN SPORADIC AD Alzheimer's & Dementia. 13: P184-P185. DOI: 10.1016/J.Jalz.2017.06.2412 |
0.541 |
|
| 2017 |
Vlassenko AG, Gordon BA, Goyal MS, Su Y, Durbin TJ, Couture LE, Holtzman DM, Morris JC, Fagan AM, Benzinger TL, Bateman RJ, Raichle ME. [IC-P-064]: BRAIN AEROBIC GLYCOLYSIS AND AD PATHOLOGY BIOMARKERS IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P53-P53. DOI: 10.1016/J.Jalz.2017.06.2337 |
0.555 |
|
| 2017 |
Mishra S, Blazey T, Su Y, Christensen J, Jackson K, Hornbeck RC, Cruchaga C, Morris JC, Ances BM, Benzinger TL, Gordon BA. [IC-P-061]: APOE4 EFFECT ON LONGITUDINAL VOLUMETRICS AND PIB ACCUMULATION IN PRECLINICAL ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P50-P50. DOI: 10.1016/J.Jalz.2017.06.2334 |
0.564 |
|
| 2017 |
Joseph-Mathurin N, Kantarci K, Jack CR, Ringman JM, Salloway S, McDade E, Clifford D, Blazey T, Friedrichsen KA, Su Y, Gordon BA, Hornbeck RC, Mills S, Ances BM, Raichle ME, ... ... Morris JC, et al. Clinical Risk Related To Cerebral Microhemorrhages In Autosomal Dominant Alzheimer’S Disease: Longitudinal Results From The Dian Study Alzheimers & Dementia. 13: 47. DOI: 10.1016/J.Jalz.2017.06.2330 |
0.511 |
|
| 2017 |
Gordon BA, Blazey T, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Fagan AM, Marcus DS, Jack CR, ... ... Morris JC, et al. [IC-P-054]: EXAMINING LONGITUDINAL NEUROIMAGING PATTERNS IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE: RESULTS FROM THE DOMINANTLY INHERITED ALZHEIMER NETWORK Alzheimer's & Dementia. 13: P44-P45. DOI: 10.1016/J.Jalz.2017.06.2327 |
0.569 |
|
| 2017 |
Strain JF, Smith R, Beaumont H, Gordon BA, Mishra S, Christensen J, Morris JC, Benzinger TL, Ances BM. [P4-244]: WHITE MATTER INTEGRITY REFLECTS TAU ACCUMULATION IN AD-DEFINED REGIONS Alzheimer's & Dementia. 13: P1370-P1371. DOI: 10.1016/J.Jalz.2017.06.2112 |
0.544 |
|
| 2017 |
Babulal GM, Stout SH, Head DM, Holtzman DM, Fagan AM, Morris JC, Roe CM. [P4-185]: NEUROPSYCHIATRIC SYMPTOMS AND ALZHEIMER DISEASE BIOMARKERS PREDICT DRIVING DECLINE Alzheimer's & Dementia. 13: P1335-P1335. DOI: 10.1016/J.Jalz.2017.06.2052 |
0.362 |
|
| 2017 |
Stout SH, Babulal GM, Ma C, Carr DB, Head DM, Grant EA, Williams MM, Holtzman DM, Fagan AM, Morris JC, Roe CM. Driving Cessation Over A 22-Year Period: Dementia Severity And Csf Biomarkers Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1811 |
0.304 |
|
| 2017 |
Han J, Besser LM, Xiong C, Kukull WA, Morris JC. [P3-291]: CHOLINESTERASE INHIBITOR USE AND COGNITIVE DECLINE IN MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P1054-P1054. DOI: 10.1016/J.Jalz.2017.06.1505 |
0.352 |
|
| 2017 |
Day GS, Cruchaga C, Wingo T, Morris JC. [P3-257]: DECODING VARIABILITY IN AGE-AT-SYMPTOMATIC-ONSET BETWEEN PARENTS AND CHILDREN WITH SPORADIC ALZHEIMER DISEASE DEMENTIA Alzheimer's & Dementia. 13: P1041-P1042. DOI: 10.1016/J.Jalz.2017.06.1471 |
0.35 |
|
| 2017 |
Schindler SE, Herries EM, Ladenson JH, Morris JC, Fagan AM. Emerging Csf Biomarkers As Predictors Of Alzheimer Disease Dementia Alzheimers & Dementia. 13: 1014. DOI: 10.1016/J.Jalz.2017.06.1418 |
0.414 |
|
| 2017 |
Schultz SA, Gordon BA, Mishra S, Su Y, Morris JC, Benzinger TL, Ances B. TAU DISTRIBUTION IN PRECLINICAL ALZHEIMER’s DISEASE: FINDINGS FROM THE KNIGHT ALZHEIMER’S DISEASE RESEARCH CENTER Alzheimer's & Dementia. 13: P144-P145. DOI: 10.1016/J.Jalz.2017.06.1029 |
0.542 |
|
| 2017 |
Joseph-Mathurin N, Su Y, Blazey T, Jasielec MS, Vlassenko AG, Friedrichsen KA, Gordon BA, Hornbeck RC, Cash L, Ances BM, Raichle ME, Brickman AM, Buckles V, Cairns NJ, Cruchaga C, ... ... Morris JC, et al. Utility Of Perfusion Pet Models As Measures Of Neurodegeneration In An Autosomal Dominant Alzheimer’S Disease Population: Report From The Dian Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1027 |
0.509 |
|
| 2016 |
Lucey BP, Mawuenyega KG, Patterson BW, Elbert DL, Ovod V, Kasten T, Morris JC, Bateman RJ. Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System. Jama Neurology. PMID 27992627 DOI: 10.1001/Jamaneurol.2016.4202 |
0.314 |
|
| 2016 |
Babulal GM, Traub CM, Webb M, Stout SH, Addison A, Carr DB, Ott BR, Morris JC, Roe CM. Creating a driving profile for older adults using GPS devices and naturalistic driving methodology. F1000research. 5: 2376. PMID 27990264 DOI: 10.12688/F1000Research.9608.2 |
0.311 |
|
| 2016 |
Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG, Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA. In vivo Detection of Microstructural Correlates of Brain Pathology in Preclinical and Early Alzheimer Disease with Magnetic Resonance Imaging. Neuroimage. PMID 27989773 DOI: 10.1016/J.Neuroimage.2016.12.026 |
0.397 |
|
| 2016 |
Suárez-Calvet M, Araque Caballero MÁ, Kleinberger G, Bateman RJ, Fagan AM, Morris JC, Levin J, Danek A, Ewers M, Haass C. Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury. Science Translational Medicine. 8: 369ra178. PMID 27974666 DOI: 10.1126/Scitranslmed.Aag1767 |
0.438 |
|
| 2016 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Salazar J, Saykin AJ, Shaw LM, Toga AW, et al. The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27931796 DOI: 10.1016/J.Jalz.2016.10.006 |
0.405 |
|
| 2016 |
Head D, Allison S, Lucena N, Hassenstab J, Morris JC. Latent structure of cognitive performance in the adult children study. Journal of Clinical and Experimental Neuropsychology. 1-16. PMID 27868476 DOI: 10.1080/13803395.2016.1252725 |
0.446 |
|
| 2016 |
Monsell SE, Mock C, Fardo DW, Bertelsen S, Cairns NJ, Roe CM, Ellingson SR, Morris JC, Goate AM, Kukull WA. Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology. Alzheimer Disease and Associated Disorders. PMID 27849641 DOI: 10.1097/Wad.0000000000000179 |
0.399 |
|
| 2016 |
Deming Y, Black K, Carrell D, Cai Y, Del-Aguila JL, Fernandez MV, Budde J, Ma S, Saef B, Howells B, Bertelsen S, Huang KL, Sutphen CL, Tarawneh R, Fagan AM, ... ... Morris JC, et al. Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40. Bmc Neurology. 16: 217. PMID 27832767 DOI: 10.1186/S12883-016-0742-9 |
0.393 |
|
| 2016 |
Baker-Nigh AT, Mawuenyega KG, Bollinger JG, Ovod V, Kasten T, Franklin EE, Liao F, Jiang H, Holtzman D, Cairns NJ, Morris JC, Bateman RJ. Human Central Nervous System (CNS) ApoE Isoforms are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared to Plasma. The Journal of Biological Chemistry. PMID 27793990 DOI: 10.1074/Jbc.M116.721779 |
0.404 |
|
| 2016 |
Natelson Love M, Clark DG, Cochran JN, Den Beste KA, Geldmacher DS, Benzinger TL, Gordon BA, Morris JC, Bateman RJ, Roberson ED. Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease. Neurobiology of Aging. PMID 27793474 DOI: 10.1016/J.Neurobiolaging.2016.09.020 |
0.567 |
|
| 2016 |
Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, ... ... Morris JC, et al. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology. PMID 27777020 DOI: 10.1016/S1474-4422(16)30229-0 |
0.402 |
|
| 2016 |
Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, ... ... Morris JC, et al. Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiology of Aging. PMID 27666590 DOI: 10.1016/J.Neurobiolaging.2016.08.023 |
0.329 |
|
| 2016 |
Fernández MV, Black K, Carrell D, Saef B, Budde J, Deming Y, Howells B, Del-Aguila JL, Ma S, Bi C, Norton J, Chasse R, Morris J, Goate A, Cruchaga C, et al. SORL1 variants across Alzheimer's disease European American cohorts. European Journal of Human Genetics : Ejhg. PMID 27650968 DOI: 10.1038/Ejhg.2016.122 |
0.377 |
|
| 2016 |
Cummings J, Aisen PS, DuBois B, Frölich L, Jack CR, Jones RW, Morris JC, Raskin J, Dowsett SA, Scheltens P. Drug development in Alzheimer's disease: the path to 2025. Alzheimer's Research & Therapy. 8: 39. PMID 27646601 DOI: 10.1186/S13195-016-0207-9 |
0.427 |
|
| 2016 |
Gordon BA, Blazey T, Su Y, Fagan AM, Holtzman DM, Morris JC, Benzinger TL. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology. Jama Neurology. PMID 27548756 DOI: 10.1001/Jamaneurol.2016.2642 |
0.584 |
|
| 2016 |
Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, ... ... Morris JC, et al. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 27521573 DOI: 10.1093/Brain/Aww200 |
0.459 |
|
| 2016 |
Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, McConathy J, Cairns NJ, Fagan AM, Morris JC, Ances BM. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy. Jama Neurology. PMID 27454922 DOI: 10.1001/Jamaneurol.2016.2078 |
0.475 |
|
| 2016 |
Day GS, Musiek ES, Roe CM, Norton J, Goate AM, Cruchaga C, Cairns NJ, Morris JC. Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study. Jama Neurology. PMID 27454811 DOI: 10.1016/J.Jalz.2016.06.1371 |
0.446 |
|
| 2016 |
Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TL, Fagan AM, Morris JC, Roe CM. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27426238 DOI: 10.1016/J.Jagp.2016.04.004 |
0.482 |
|
| 2016 |
Vlassenko AG, McCue L, Jasielec MS, Su Y, Gordon BA, Xiong C, Holtzman DM, Benzinger TL, Morris JC, Fagan AM. Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease. Annals of Neurology. PMID 27398953 DOI: 10.1002/Ana.24719 |
0.587 |
|
| 2016 |
Muenchhoff J, Poljak A, Thalamuthu A, Gupta VB, Chatterjee P, Raftery M, Masters CL, Morris JC, Bateman RJ, Fagan AM, Martins RN, Sachdev PS. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. Scientific Reports. 6: 29078. PMID 27381087 DOI: 10.1038/Srep29078 |
0.374 |
|
| 2016 |
Vos SJ, Gordon BA, Su Y, Visser PJ, Holtzman DM, Morris JC, Fagan AM, Benzinger TL. NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers. Neurobiology of Aging. 44: 1-8. PMID 27318129 DOI: 10.1016/J.Neurobiolaging.2016.03.025 |
0.574 |
|
| 2016 |
Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, Aldea P, McConathy J, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances BM, Benzinger TL. The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. Brain : a Journal of Neurology. PMID 27286736 DOI: 10.1093/Brain/Aww139 |
0.584 |
|
| 2016 |
Hassenstab J, Chasse R, Grabow P, Benzinger TL, Fagan AM, Xiong C, Jasielec M, Grant E, Morris JC. Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning. Neurobiology of Aging. 43: 23-33. PMID 27255812 DOI: 10.1016/J.Neurobiolaging.2016.03.014 |
0.373 |
|
| 2016 |
Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TL, et al. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease. Science Translational Medicine. 8: 338ra66. PMID 27169802 DOI: 10.1126/Scitranslmed.Aaf2362 |
0.604 |
|
| 2016 |
Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague S, Xiong C, Grant EA, Campbell A, Ott BR, ... ... Morris JC, et al. Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals. Alzheimer Disease and Associated Disorders. PMID 27128959 DOI: 10.1097/Wad.0000000000000154 |
0.483 |
|
| 2016 |
Ingber AP, Hassenstab J, Fagan AM, Benzinger TL, Grant EA, Holtzman DM, Morris JC, Roe CM. Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27104893 DOI: 10.3233/Jad-150478 |
0.436 |
|
| 2016 |
Tarawneh R, D'Angelo G, Crimmins D, Herries E, Griest T, Fagan AM, Zipfel GJ, Ladenson JH, Morris JC, Holtzman DM. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease. Jama Neurology. PMID 27018940 DOI: 10.1001/Jamaneurol.2016.0086 |
0.403 |
|
| 2016 |
Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Morris JC, et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network. Annals of Neurology. PMID 27016429 DOI: 10.1002/ana.24647 |
0.464 |
|
| 2016 |
Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, ... ... Morris JC, et al. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. Plos One. 11: e0152082. PMID 27010959 DOI: 10.1371/Journal.Pone.0152082 |
0.42 |
|
| 2016 |
Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC. Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study. Neurology. PMID 27009258 DOI: 10.1212/Wnl.0000000000002593 |
0.432 |
|
| 2016 |
Molinuevo JL, Cami J, Carné X, Carrillo MC, Georges J, Isaac MB, Khachaturian Z, Kim SY, Morris JC, Pasquier F, Ritchie C, Sperling R, Karlawish J. Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26988427 DOI: 10.1016/J.Jalz.2016.01.009 |
0.333 |
|
| 2016 |
Allison SL, Fagan AM, Morris JC, Head D. Spatial Navigation in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26967209 DOI: 10.3233/Jad-150855 |
0.447 |
|
| 2016 |
Chatterjee P, Lim WL, Shui G, Gupta VB, James I, Fagan AM, Xiong C, Sohrabi HR, Taddei K, Brown BM, Benzinger T, Masters C, Snowden SG, Wenk MR, Bateman RJ, ... Morris JC, et al. Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 26836186 DOI: 10.3233/Jad-150948 |
0.384 |
|
| 2016 |
Brier MR, McCarthy JE, Benzinger TL, Stern A, Su Y, Friedrichsen KA, Morris JC, Ances BM, Vlassenko AG. Local and distributed PiB accumulation associated with development of preclinical Alzheimer's disease. Neurobiology of Aging. 38: 104-11. PMID 26827648 DOI: 10.1016/J.Neurobiolaging.2015.10.025 |
0.474 |
|
| 2016 |
Day GS, Gordon BA, Benzinger TL, Morris JC. P4-337: IN VIVO
Quantification of Regional TAU Deposition in Patients with Progressive Posterior Cortical Dysfunction Alzheimer's & Dementia. 12: P1163-P1164. DOI: 10.1016/J.Jalz.2016.07.081 |
0.514 |
|
| 2016 |
Petros J, Hassenstab J, Snitz BE, Zhou Y, Ringman JM, McDade E, Wang G, Balota DA, Aschenbrenner AJ, Benzinger TL, Cruchaga C, Fagan AM, Goate AM, Holtzman DM, Buckles V, ... ... Morris JC, et al. Dynamic Relationships Between “Big Five” Personality Traits, Alzheimer’S Disease Biomarkers, And Cognition In Autosomal Dominant Alzheimer’S Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.970 |
0.338 |
|
| 2016 |
McDade E, Weng H, Wang G, Xiong C, Fagan AM, Hassenstab J, Marcus DS, Morris JC, Benzinger TL, Cairns NJ, Goate AM, Buckles V, Holtzman DM, Berman S, Ghetti B, et al. O5-02-01: Longitudinal Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease: The Dominantly Inherited Alzheimer Network Alzheimer's & Dementia. 12: P378-P379. DOI: 10.1016/J.Jalz.2016.06.710 |
0.381 |
|
| 2016 |
Benzinger TLS, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Hornbeck RC, Mishra S, Aldea P, Cash L, Ances B, McConathy J, Koeppe RA, McDade E, Cairns NJ, Morris JC, et al. Tau Pet Imaging With Av-1451 In Autosomal Dominant Alzheimer'S Disease: Update From The Dominantly Inherited Alzheimer Network (Dian) Alzheimers & Dementia. 12: 378. DOI: 10.1016/J.Jalz.2016.06.709 |
0.586 |
|
| 2016 |
Lim YY, Hassenstab J, Cruchaga C, Goate AM, Fagan AM, Lee Smith Benzinger T, Maruff P, Snyder PJ, Masters CL, Ricardo A, Chhatwal JP, Farlow MR, Graff-Radford NR, Laske C, Levin J, ... ... Morris JC, et al. F5-02-03: BDNF VAL66MET Moderates Cognitive Impairment, Neuronal Dysfunction and TAU in Preclinical Autosomal Dominant Alzheimer's Disease Alzheimer's & Dementia. 12: P369-P369. DOI: 10.1016/J.Jalz.2016.06.689 |
0.37 |
|
| 2016 |
Cash DM, Kinnunen KM, Weston PS, Ryan NS, Modat M, Bateman R, Morris JC, Ourselin S, Rossor MN, Benzinger TLS, Fox NC. Longitudinal Atrophy In Autosomal Dominant Ad And Sporadic Ad: Lessons From Dian Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.688 |
0.346 |
|
| 2016 |
Weninger S, Reiman EM, Langbaum JB, Tariot PN, Lopera F, Bateman R, Morris JC, Sperling RA, Aisen PS, Roses AD, Welsh-Bohmer KA, Carrillo M. F4-03-01: Collaboration for Alzheimer's Prevention (CAP): Advancing the Evaluation of Preclinical Alzheimer's Disease Treatments Alzheimer's & Dementia. 12: P325-P326. DOI: 10.1016/J.Jalz.2016.06.596 |
0.383 |
|
| 2016 |
Deming Y, Harari O, Black K, Carrell D, Cai Y, Del-Aguila JL, Fernandez V, Budde J, Ma S, Saef B, Bertelsen S, Kauwe J, Fagan AM, Holtzman DM, Morris JC, et al. Cerebrospinal Fluid Levels Of Amyloid Beta And Tau As Endophenotypes Reveal Novel Variants Potentially Informative For Alzheimer'S Disease Alzheimers & Dementia. 12: 252. DOI: 10.1016/J.Jalz.2016.06.452 |
0.369 |
|
| 2016 |
Joseph-Mathurin N, Vlassenko AG, Fagan AM, Su Y, Friedrichsen KA, Owen CJ, Gordon BA, Hornbeck RC, Koeppe RA, Xiong C, Morris JC, Bateman R, Benzinger TL. Neuronal Injury And Degeneration Evaluated With Imaging And Csf Biomarkers In Autosomal Dominant Alzheimer'S Disease: Results From The Dian Study Alzheimers & Dementia. 12: 246. DOI: 10.1016/J.Jalz.2016.06.440 |
0.542 |
|
| 2016 |
Lee S, Zimmerman ME, Viqar F, Narkhede A, Tosto G, Lee Smith Benzinger T, Marcus DS, Goate AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, ... ... Morris JC, et al. O2-03-02: are White Matter Hyperintensities a Core Feature of Alzheimer’s Disease or Just a Reflection of Amyloid Angiopathy? Evidence From the Dominantly Inherited Alzheimer Network (DIAN) Alzheimer's & Dementia. 12: P226-P226. DOI: 10.1016/J.Jalz.2016.06.406 |
0.343 |
|
| 2016 |
Gordon BA, Blazey T, Morris JC, Holtzman DM, Fagan AM, Benzinger TL. O1-07-04: Longitudinal Amyloid Deposition and Hippocampal Volume in Suspected Non-Alzheimer Pathophysiology and Preclinical Alzheimer's Disease Alzheimer's & Dementia. 12: P191-P191. DOI: 10.1016/J.Jalz.2016.06.332 |
0.579 |
|
| 2016 |
Friedrichsen KA, Ghoshal N, Joseph-Mathurin N, Mishra S, Su Y, Christensen J, Aldea P, McConathy J, Gordon BA, Ances B, Cairns NJ, Morris JC, Benzinger TL. IC-P-206: Similarities and Differences in Patterns of [F18]-Av-1451 And [F18]-FDG in Frontotemporal Dementia Alzheimer's & Dementia. 12: P147-P147. DOI: 10.1016/J.Jalz.2016.06.238 |
0.485 |
|
| 2016 |
Friedrichsen KA, Mishra S, Gordon BA, Ghoshal N, Su Y, Joseph-Mathurin N, Christensen J, Aldea P, McConathy J, Ances B, Cairns NJ, Morris JC, Benzinger TL. IC-P-204: Principal Component Analysis of [18F]-Av-1451 TAU PET in Alzheimer’s Disease and Frontotemporal Dementia Alzheimer's & Dementia. 12: P145-P146. DOI: 10.1016/J.Jalz.2016.06.236 |
0.545 |
|
| 2016 |
Wang Q, Wang Y, Christensen J, Shimony JS, Liu J, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TLS. Imaging Marker Of Neuroinflammation Predicts Progression In Alzheimer'S Disease Alzheimers & Dementia. 12: 1076. DOI: 10.1016/J.Jalz.2016.06.2252 |
0.372 |
|
| 2016 |
Laske C, Preische O, Graeber S, Jucker M, Bateman R, Morris JC, Mueller S. Decreased Body Mass Index In The Preclinical Stage Of Alzheimer'S Disease: Evidence From The Dominantly Inherited Alzheimer Network Alzheimers & Dementia. 12: 1069. DOI: 10.1016/J.Jalz.2016.06.2236 |
0.364 |
|
| 2016 |
Day GS, Alcazaren G, Musiek ES, Morris JC. P4-131: Evaluating the Contributions of Common Neurodegenerative Dementing Illnesses to Rapidly Progressive Dementia in the Outpatient Clinic Alzheimer's & Dementia. 12: P1063-P1064. DOI: 10.1016/J.Jalz.2016.06.2222 |
0.337 |
|
| 2016 |
Roe CM, Head DM, Babulal GM, Stout SH, Ghoshal N, Vernon EK, Selsor N, Fierberg R, Shulman N, Johnson A, Fague MS, Xiong C, Grant EA, Campbell A, Holtzman DM, ... ... Morris JC, et al. P4-150: Preclinical Alzheimer’s Disease Predicts Longitudinal Onset of Driving Difficulties Among Cognitively Normal Persons Alzheimer's & Dementia. 12: P1071-P1071. DOI: 10.1016/J.Jalz.2016.06.2215 |
0.334 |
|
| 2016 |
Ances B, Brier MR, Gordon BA, Friedrichsen KA, McCarthy JE, Stern A, Christensen J, Owen CJ, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, et al. IC-P-179: TAU Imaging Relationships With Amyloid B Imaging, CSF TAU/AB42
, and Cognition in Alzheimer’s Disease Alzheimer's & Dementia. 12: P130-P131. DOI: 10.1016/J.Jalz.2016.06.210 |
0.557 |
|
| 2016 |
Wang Q, Wang Y, Shimony JS, Owen CJ, Liu J, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TLS. Simultaneous Quantification Of White Matter Abnormalities And Vasogenic Edema In Early Alzheimer Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.203 |
0.367 |
|
| 2016 |
Wang Q, Wang Y, Christensen J, Liu J, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TLS. Imaging Marker Of Neuroinflammation Predicts Disease Progression In Alzheimer Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.200 |
0.372 |
|
| 2016 |
Schwarz AJ, Gordon BA, Tanenbaum A, Morris JC, Benzinger TL, Ances B. P3-283: Functional Connectivity with Anterior Temporal Lobe Regions Ordered According to the Braak Progression Scheme Reveals Sequential Coupling to Default Mode and Then Sensory Networks Alzheimer's & Dementia. 12: P946-P946. DOI: 10.1016/J.Jalz.2016.06.1946 |
0.456 |
|
| 2016 |
Kim S, Nho K, Shen L, Franklin EE, Morris JC, Cairns NJ, Saykin AJ. Influence Of Parkinson’S Disease Candidate Genes On Lewy Body Pathology In Autopsy-Confirmed Alzheimer'S Disease Cases Alzheimers & Dementia. 12: 854. DOI: 10.1016/J.Jalz.2016.06.1748 |
0.378 |
|
| 2016 |
Cash DM, Ridgway GR, Kinnunen KM, Benzinger TLS, Wallon D, Jack CR, Bateman R, Morris JC, Rossor MN, Ourselin S, Fox NC. A Longitudinal Morphometric Study Of Familial Alzheimer’S Disease: Results From Dian Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.172 |
0.346 |
|
| 2016 |
Gordon BA, Xiong C, Holtzman DM, Fagan AM, Morris JC, Benzinger TL. IC-P-139: Critical Analysis of Biomarker Cutoffs in Alzheimer Disease Alzheimer's & Dementia. 12: P103-P104. DOI: 10.1016/J.Jalz.2016.06.169 |
0.559 |
|
| 2016 |
Joseph-Mathurin N, Vlassenko AG, Fagan AM, Su Y, Friedrichsen KA, Owen CJ, Gordon BA, Hornbeck RC, Koeppe RA, Xiong C, Morris JC, Bateman R, Benzinger TL. Neuronal Injury And Degeneration Evaluated With Imaging And Csf Biomarkers In Autosomal Dominant Ad: Results From The Dian Study Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.147 |
0.513 |
|
| 2016 |
Wang Q, Wang Y, Shimony JS, Liu J, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TL. White Matter Neuroinflammation In Preclinical Alzheimer Disease Can Be Quantified By Diffusion Basis Spectrum Imaging Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1025 |
0.325 |
|
| 2016 |
Gordon BA, Friedrichsen KA, Brier MR, Blazey T, Su Y, Christensen J, McConathy J, Aldea P, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances B, Benzinger TL. P1-263: Relating PET and CSF Measure of TAU Pathology Alzheimer's & Dementia. 12: P513-P514. DOI: 10.1016/J.Jalz.2016.06.1012 |
0.531 |
|
| 2016 |
Mishra S, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Aldea P, Cairns NJ, Morris JC, Ances B, Benzinger TL. IC-01-03: Classifying TAU Pet Positivity With [18F]-AV-1451 in Preclinical Alzheimer's Disease Alzheimer's & Dementia. 12: P2-P3. DOI: 10.1016/J.Jalz.2016.06.063 |
0.553 |
|
| 2015 |
Benitez BA, Cairns NJ, Schmidt RE, Morris JC, Norton JB, Cruchaga C, Sands MS. Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss. Acta Neuropathologica Communications. 3: 73. PMID 26610600 DOI: 10.1186/S40478-015-0256-5 |
0.369 |
|
| 2015 |
Ringman JM, Liang LJ, Zhou Y, Vangala S, Teng E, Kremen S, Wharton D, Goate A, Marcus DS, Farlow M, Ghetti B, McDade E, Masters CL, Mayeux RP, Rossor M, ... ... Morris JC, et al. Erratum: Early behavioural changes in familial Alzheimers disease in the Dominantly Inherited Alzheimer Network (Brain (2015) 138 (103645) (10.1093/brain/awv004)) Brain. 138. PMID 26598496 DOI: 10.1093/Brain/Awv210 |
0.341 |
|
| 2015 |
Deming Y, Xia J, Cai Y, Lord J, Holmans P, Bertelsen S, Holtzman D, Morris JC, Bales K, Pickering EH, Kauwe J, Goate A, Cruchaga C. A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin. Neurobiology of Aging. PMID 26545630 DOI: 10.1016/J.Jalz.2015.07.374 |
0.436 |
|
| 2015 |
Gooblar J, Roe CM, Selsor NJ, Gabel MJ, Morris JC. Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results. Jama Neurology. 1-7. PMID 26501506 DOI: 10.1001/Jamaneurol.2015.2875 |
0.381 |
|
| 2015 |
Hassenstab J, Monsell SE, Mock C, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology. Journal of Neuropathology and Experimental Neurology. 74: 1086-92. PMID 26469250 DOI: 10.1097/Nen.0000000000000254 |
0.444 |
|
| 2015 |
Reiman EM, Langbaum JB, Tariot PN, Lopera F, Bateman RJ, Morris JC, Sperling RA, Aisen PS, Roses AD, Welsh-Bohmer KA, Carrillo MC, Weninger S. CAP-advancing the evaluation of preclinical Alzheimer disease treatments. Nature Reviews. Neurology. PMID 26416539 DOI: 10.1038/Nrneurol.2015.177 |
0.445 |
|
| 2015 |
Aschenbrenner AJ, Balota DA, Fagan AM, Duchek JM, Benzinger TL, Morris JC. Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study. Journal of the International Neuropsychological Society : Jins. 21: 573-83. PMID 26416094 DOI: 10.1017/S1355617715000776 |
0.43 |
|
| 2015 |
Kester MI, Teunissen CE, Sutphen C, Herries EM, Ladenson JH, Xiong C, Scheltens P, van der Flier WM, Morris JC, Holtzman DM, Fagan AM. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort. Alzheimer's Research & Therapy. 7: 59. PMID 26383836 DOI: 10.1186/S13195-015-0142-1 |
0.345 |
|
| 2015 |
Kester MI, Teunissen CE, Crimmins DL, Herries EM, Ladenson JH, Scheltens P, van der Flier WM, Morris JC, Holtzman DM, Fagan AM. Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease. Jama Neurology. 1-7. PMID 26366630 DOI: 10.1001/Jamaneurol.2015.1867 |
0.33 |
|
| 2015 |
Morley JE, Morris JC, Berg-Weger M, Borson S, Carpenter BD, Del Campo N, Dubois B, Fargo K, Fitten LJ, Flaherty JH, Ganguli M, Grossberg GT, Malmstrom TK, Petersen RD, Rodriguez C, et al. Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference. Journal of the American Medical Directors Association. 16: 731-9. PMID 26315321 DOI: 10.1016/J.Jamda.2015.06.017 |
0.314 |
|
| 2015 |
Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, ... ... Morris JC, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/Wnl.0000000000001903 |
0.548 |
|
| 2015 |
Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease. Alzheimer's Research & Therapy. 7: 50. PMID 26203303 DOI: 10.1186/S13195-015-0135-0 |
0.361 |
|
| 2015 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, et al. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 865-84. PMID 26194320 DOI: 10.1016/J.Jalz.2015.04.005 |
0.492 |
|
| 2015 |
Franklin EE, Perrin RJ, Vincent B, Baxter M, Morris JC, Cairns NJ. Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 815-22. PMID 26194314 DOI: 10.1016/J.Jalz.2015.05.010 |
0.458 |
|
| 2015 |
Aschenbrenner AJ, Balota DA, Gordon BA, Ratcliff R, Morris JC. A Diffusion Model Analysis of Episodic Recognition in Preclinical Individuals With a Family History for Alzheimer's Disease: The Adult Children Study. Neuropsychology. PMID 26192539 DOI: 10.1037/Neu0000222 |
0.536 |
|
| 2015 |
Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG, Benzinger TL, Stoops EE, Vanderstichele HM, Brix B, Darby HD, Vandijck ML, Ladenson JH, Morris JC, Holtzman DM, et al. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age. Jama Neurology. 72: 1029-1042. PMID 26147946 DOI: 10.1001/Jamaneurol.2015.1285 |
0.493 |
|
| 2015 |
Gordon BA, Najmi S, Hsu P, Roe CM, Morris JC, Benzinger TL. The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia. Neuroimage. Clinical. 8: 246-52. PMID 26106548 DOI: 10.1016/J.Nicl.2015.04.017 |
0.571 |
|
| 2015 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, et al. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: e1-e120. PMID 26073027 DOI: 10.1016/J.Jalz.2014.11.001 |
0.51 |
|
| 2015 |
Patterson BW, Elbert DL, Mawuenyega KG, Kasten T, Ovod V, Ma S, Xiong C, Chott R, Yarasheski K, Sigurdson W, Zhang L, Goate A, Benzinger T, Morris JC, Holtzman D, et al. Age and amyloid effects on human CNS amyloid-beta kinetics. Annals of Neurology. PMID 26040676 DOI: 10.1002/Ana.24454 |
0.395 |
|
| 2015 |
Hassenstab J, Ruvolo D, Jasielec M, Xiong C, Grant E, Morris JC. Absence of Practice Effects in Preclinical Alzheimer's Disease. Neuropsychology. PMID 26011114 DOI: 10.1037/Neu0000208 |
0.454 |
|
| 2015 |
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Morris JC, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668 |
0.364 |
|
| 2015 |
Chung EJ, Babulal GM, Monsell SE, Cairns NJ, Roe CM, Morris JC. Clinical Features of Alzheimer Disease With and Without Lewy Bodies. Jama Neurology. PMID 25985321 DOI: 10.1016/J.Jalz.2015.06.406 |
0.461 |
|
| 2015 |
Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC, et al. Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 25964057 DOI: 10.1111/Neup.12205 |
0.465 |
|
| 2015 |
Laske C, Sohrabi HR, Jasielec MS, Müller S, Koehler NK, Gräber S, Förster S, Drzezga A, Mueller-Sarnowski F, Danek A, Jucker M, Bateman RJ, Buckles V, Saykin AJ, Martins RN, ... Morris JC, et al. Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study. Biomed Research International. 2015: 828120. PMID 25922840 DOI: 10.1155/2015/828120 |
0.386 |
|
| 2015 |
Tolea MI, Morris JC, Galvin JE. Trajectory of Mobility Decline by Type of Dementia. Alzheimer Disease and Associated Disorders. PMID 25886717 DOI: 10.1097/Wad.0000000000000091 |
0.372 |
|
| 2015 |
Tolea MI, Morris JC, Galvin JE. Longitudinal associations between physical and cognitive performance among community-dwelling older adults. Plos One. 10: e0122878. PMID 25875165 DOI: 10.1371/Journal.Pone.0122878 |
0.333 |
|
| 2015 |
Tarawneh R, Head D, Allison S, Buckles V, Fagan AM, Ladenson JH, Morris JC, Holtzman DM. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease. Jama Neurology. 72: 656-65. PMID 25867677 DOI: 10.1001/Jamaneurol.2015.0202 |
0.425 |
|
| 2015 |
Johnson DK, Langford Z, Garnier-Villarreal M, Morris JC, Galvin JE. Onset of Mild Cognitive Impairment in Parkinson Disease. Alzheimer Disease and Associated Disorders. PMID 25850732 DOI: 10.1097/Wad.0000000000000088 |
0.303 |
|
| 2015 |
Su Y, Blazey TM, Snyder AZ, Raichle ME, Hornbeck RC, Aldea P, Morris JC, Benzinger TL. Quantitative amyloid imaging using image-derived arterial input function. Plos One. 10: e0122920. PMID 25849581 DOI: 10.1371/Journal.Pone.0122920 |
0.312 |
|
| 2015 |
Kim A, Fagan AM, Goate AM, Benzinger TL, Morris JC, Head D. Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. Cognitive, Affective & Behavioral Neuroscience. PMID 25784293 DOI: 10.3758/S13415-015-0343-X |
0.301 |
|
| 2015 |
Wang L, Benzinger TL, Hassenstab J, Blazey T, Owen C, Liu J, Fagan AM, Morris JC, Ances BM. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease. Neurology. 84: 1254-60. PMID 25716355 DOI: 10.1212/Wnl.0000000000001401 |
0.517 |
|
| 2015 |
Gordon BA, Zacks JM, Blazey T, Benzinger TL, Morris JC, Fagan AM, Holtzman DM, Balota DA. Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers. Neurobiology of Aging. 36: 1771-9. PMID 25708908 DOI: 10.1016/J.Neurobiolaging.2015.01.019 |
0.555 |
|
| 2015 |
Ringman JM, Liang LJ, Zhou Y, Vangala S, Teng E, Kremen S, Wharton D, Goate A, Marcus DS, Farlow M, Ghetti B, McDade E, Masters CL, Mayeux RP, Rossor M, ... ... Morris JC, et al. Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network. Brain : a Journal of Neurology. 138: 1036-45. PMID 25688083 DOI: 10.1093/Brain/Awv004 |
0.367 |
|
| 2015 |
Chatterjee P, Gupta VB, Fagan AM, Jasielec MS, Xiong C, Sohrabi HR, Dhaliwal S, Taddei K, Bourgeat P, Brown BM, Benzinger T, Bateman RJ, Morris JC, Martins RN. Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset. Current Alzheimer Research. 12: 157-64. PMID 25654503 DOI: 10.2174/1567205012666150204125732 |
0.417 |
|
| 2015 |
Masters MC, Morris JC, Roe CM. "Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis. Neurology. 84: 617-22. PMID 25589671 DOI: 10.1212/Wnl.0000000000001238 |
0.36 |
|
| 2015 |
Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Morris JC, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157 |
0.452 |
|
| 2015 |
Ming J, Harms MP, Morris JC, Beg MF, Wang L. Integrated cortical structural marker for Alzheimer's disease. Neurobiology of Aging. 36: S53-9. PMID 25444604 DOI: 10.1016/J.Neurobiolaging.2014.03.042 |
0.369 |
|
| 2015 |
Hsu PJ, Shou H, Benzinger T, Marcus D, Durbin T, Morris JC, Sheline YI. Amyloid burden in cognitively normal elderly is associated with preferential hippocampal subfield volume loss. Journal of Alzheimer's Disease : Jad. 45: 27-33. PMID 25428255 DOI: 10.3233/Jad-141743 |
0.432 |
|
| 2015 |
Shim YS, Yang DW, Roe CM, Coats MA, Benzinger TL, Xiong C, Galvin JE, Cairns NJ, Morris JC. Pathological correlates of white matter hyperintensities on magnetic resonance imaging. Dementia and Geriatric Cognitive Disorders. 39: 92-104. PMID 25401390 DOI: 10.1159/000366411 |
0.417 |
|
| 2015 |
Aschenbrenner AJ, Balota DA, Tse CS, Fagan AM, Holtzman DM, Benzinger TL, Morris JC. Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults. Neuropsychology. 29: 368-81. PMID 25222200 DOI: 10.1037/Neu0000133 |
0.458 |
|
| 2015 |
Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm AC, Hensch T, ... ... Morris JC, et al. At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 70-98. PMID 25022540 DOI: 10.1016/J.Jalz.2014.04.514 |
0.383 |
|
| 2015 |
Gooblar J, Carpenter BD, Coats MA, Morris JC, Snider BJ. The influence of cerebrospinal fluid (CSF) biomarkers on clinical dementia evaluations. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 533-540.e2. PMID 25022536 DOI: 10.1016/J.Jalz.2014.04.517 |
0.409 |
|
| 2015 |
Hurth K, Tarawneh R, Ghoshal N, Benzinger TL, Clifford DB, Geschwind M, Morris JC, Galvin JE, Schmidt RE, Cairns NJ. Whipple's disease masquerades as dementia with Lewy bodies. Alzheimer Disease and Associated Disorders. 29: 85-9. PMID 23995819 DOI: 10.1097/Wad.0B013E3182A715Da |
0.404 |
|
| 2015 |
Aschenbrenner AJ, Balota DA, Gordon BA, Ratcliff R, Morris JC. A Diffusion Model Analysis of Episodic Recognition in Preclinical Individuals With a Family History for Alzheimer's Disease: The Adult Children Study Neuropsychology. DOI: 10.1037/neu0000222 |
0.455 |
|
| 2015 |
Gordon BA, Najmi S, Hsu P, Roe CM, Morris JC, Benzinger TLS. The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia Neuroimage: Clinical. 8: 246-252. DOI: 10.1016/j.nicl.2015.04.017 |
0.502 |
|
| 2015 |
Kester MI, Teunissen CE, Crimmins DL, Macy EM, Ladenson JH, Scheltens P, Flier WMvd, Morris JC, Holtzman DM, Fagan AM. Neurogranin, a CSF biomarker for synaptic loss, predicts decline to dementia due to Alzheimer's disease Alzheimers & Dementia. 11: 326. DOI: 10.1016/J.Jalz.2015.07.471 |
0.385 |
|
| 2015 |
Morris JC. Clinical and research utility of Alzheimer's biomarkers Alzheimers & Dementia. 11: 311. DOI: 10.1016/J.Jalz.2015.07.443 |
0.33 |
|
| 2015 |
Cairns NJ, Perrin RJ, Franklin EE, Vincent B, Carter D, Morris JC. O4-02-01: Age-related neuropathology helps distinguish autosomal dominant from late-onset Alzheimer disease Alzheimer's & Dementia. 11: P269-P269. DOI: 10.1016/J.Jalz.2015.07.351 |
0.35 |
|
| 2015 |
Perrin RJ, Weng H, Bales KR, Morris JC, Benzinger TL, Fagan AM, Xiong C, Holtzman DM. O3-14-03: Novel fluid biomarkers for brain amyloid and dementia risk in presymptomatic Alzheimer disease Alzheimer's & Dementia. 11: P255-P255. DOI: 10.1016/J.Jalz.2015.07.317 |
0.379 |
|
| 2015 |
Monsell SE, Hassenstab J, Mock C, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological markers of cognitive decline in persons with Alzheimer’s disease neuropathology Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.291 |
0.32 |
|
| 2015 |
Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague MS, Xiong C, Grant E, Campbell A, Holtzman DM, ... ... Morris JC, et al. P2-130: Amyloid imaging and cerebrospinal fluid biomarkers predict driving performance in preclinical Alzheimer's disease Alzheimer's & Dementia. 11: P533-P534. DOI: 10.1016/J.Jalz.2015.06.668 |
0.393 |
|
| 2015 |
Day GS, Lim TS, Hassenstab J, Grant EA, Goate A, Morris JC, Cairns NJ. Differentiating corticobasal degeneration and Alzheimer disease by longitudinal clinical and cognitive features Alzheimers & Dementia. 11: 525. DOI: 10.1016/J.Jalz.2015.06.646 |
0.359 |
|
| 2015 |
Huff MJ, Balota DA, Aschenbrenner AJ, Duchek JM, Fagan AM, Holtzman DM, Benzinger TL, Morris JC. P2-085: Task-switching errors show sensitivity to preclinical Alzheimer's disease biomarkers Alzheimer's & Dementia. 11: P516-P516. DOI: 10.1016/J.Jalz.2015.06.622 |
0.334 |
|
| 2015 |
Del-Aguila JL, Gross AL, Sutti S, Sherva R, Mukherjee S, Crane PK, Goate A, Morris JC, Green RC, Cruchaga C. Identification of genetic variants associated with Alzheimer's disease: Progression rate Alzheimers & Dementia. 11: 487. DOI: 10.1016/J.Jalz.2015.06.552 |
0.349 |
|
| 2015 |
Babulal GM, Vernon EK, Ghoshal N, Head DM, Barco PP, Carr DB, Morris JC, Roe CM. P1-283: The relationship between mood states and preclinical Alzheimer disease in older adults Alzheimer's & Dementia. 11: P463-P463. DOI: 10.1016/J.Jalz.2015.06.484 |
0.331 |
|
| 2015 |
Xiong C, Jasielec MS, Fagan AM, Benzinger TL, Head DM, Hassenstab J, Grant E, Buckles V, Moulder KL, Morris JC. P1-106: Longitudinal biomarker connectivity on middle-aged asymptomatic individuals and optimal design on prevention trials of Alzheimer's disease Alzheimer's & Dementia. 11: P379-P379. DOI: 10.1016/J.Jalz.2015.06.304 |
0.355 |
|
| 2015 |
Hassenstab J, Lim Y, Fagan AM, Ma S, Xiong C, Buckles V, Bateman R, Morris JC. CSF tau predicts working memory and global cognitive decline in autosomal dominant Alzheimer’s disease Alzheimers & Dementia. 11: 379. DOI: 10.1016/J.Jalz.2015.06.302 |
0.327 |
|
| 2015 |
Fleisher M, Jilakara B, Grant E, Morris JC, Snider BJ. P1-098: Utility and impact of cerebrospinal fluid studies on dementia diagnosis in a specialty dementia practice Alzheimer's & Dementia. 11: P376-P376. DOI: 10.1016/J.Jalz.2015.06.295 |
0.329 |
|
| 2015 |
Friedrichsen KA, Benzinger TLS, Joseph-Mathurin N, Fagan AM, Cairns NJ, Stevenson TA, Su Y, Christensen J, McConathy J, Gordon B, McFarlane S, Ances B, Morris JC. Patterns of tau binding in T807-PET imaging Alzheimers & Dementia. 11: 110. DOI: 10.1016/J.Jalz.2015.06.187 |
0.483 |
|
| 2015 |
Schindler SE, Jasielec MS, Xiong C, Fagan AM, Morris JC, Hassenstab J. P4-118: Neuropsychological determinants of stage 3 of preclinical Alzheimer disease Alzheimer's & Dementia. 11: P823-P823. DOI: 10.1016/J.Jalz.2015.06.1824 |
0.381 |
|
| 2015 |
Monsell SE, Mock C, Fardo DW, Bertelsen S, Cairns NJ, Roe CM, Morris JC, Goate A, Kukull W. Genetic differences between symptomatic and asymptomatic persons with Alzheimer's disease neuropathologic change Alzheimers & Dementia. 11: 767. DOI: 10.1016/J.Jalz.2015.06.1711 |
0.357 |
|
| 2015 |
Brier MR, McCarthy JE, Benzinger TL, Su Y, Friedrichsen KA, Morris JC, Ances B, Vlassenko A. P3-167: Predicting and characterizing development of preclinical Alzheimer's disease Alzheimer's & Dementia. 11: P693-P693. DOI: 10.1016/J.Jalz.2015.06.1538 |
0.386 |
|
| 2015 |
Wang Q, Wang Y, Shimony JS, Fagan AM, Cairns NJ, Ances B, Morris JC, Benzinger TLS. Diffusion tensor imaging detected neurodegeneration in preclinical Alzheimer disease Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.1525 |
0.336 |
|
| 2015 |
Owen CJ, Gordon B, Brier MR, Wang L, Wang Q, Joseph-Mathurin N, Su Y, Vlassenko A, Blazey T, Speidel B, LaMontagne P, Marcus DS, Friedrichsen KA, Hornbeck RC, Jackson K, ... ... Morris JC, et al. IC-P-100: The ILP: A new tool for evaluating preclinical Alzheimer's disease using volumetric MRI in a single participant Alzheimer's & Dementia. 11: P68-P68. DOI: 10.1016/J.Jalz.2015.06.121 |
0.554 |
|
| 2015 |
Joseph-Mathurin N, Tang M, Friedrichsen KA, Owen CJ, Su Y, Hornbeck RC, Stevenson TA, Cash L, Raichle ME, Gordon B, Preboske GM, Koeppe RA, Jack CR, Goate A, Cruchaga C, ... ... Morris JC, et al. Amyloid load increase and cerebral microbleed prevalence differ as a function of the position of the mutation within the PSEN1 coding sequence Alzheimers & Dementia. 11: 172. DOI: 10.1016/J.Jalz.2015.06.072 |
0.47 |
|
| 2015 |
Gordon BA, Hassenstab J, Fagan AM, Morris JC, Benzinger TL. IC-P-021: Lower body mass index is associated with greater Alzheimer pathology in asymptomatic individuals Alzheimer's & Dementia. 11: P25-P25. DOI: 10.1016/J.Jalz.2015.06.041 |
0.554 |
|
| 2015 |
Gordon BA, Vos S, Morris JC, Holtzman DM, Fagan AM, Benzinger TL. IC-P-020: Comparison of nia-aa preclinical Alzheimer's disease staging with CSF and neuroimaging biomarkers Alzheimer's & Dementia. 11: P24-P25. DOI: 10.1016/J.Jalz.2015.06.040 |
0.566 |
|
| 2015 |
Joseph-Mathurin N, Su Y, Vlassenko A, Jasielec MS, Blazey T, Friedrichsen KA, Owen CJ, Hornbeck RC, Stevenson TA, Cash L, Xiong C, Ringman JM, Brickman AM, Koeppe RA, Ances B, ... ... Morris JC, et al. IC-03-02: Early frame of PiB and FDG in autosomal dominant Alzheimer's disease: Similarity, discrepancy, and clinical implication Alzheimer's & Dementia. 11: P8-P9. DOI: 10.1016/J.Jalz.2015.06.013 |
0.373 |
|
| 2014 |
Sheline YI, West T, Yarasheski K, Jasielec MS, Hettinger JC, Tripoli DL, Xiong C, Frederiksen C, Grzelak MV, Bateman RJ, Morris JC, Lee JM, Cirrito JR. Reply to comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice". Science Translational Medicine. 6: 268lr4. PMID 25540323 DOI: 10.1126/Scitranslmed.3010609 |
0.365 |
|
| 2014 |
Xiong C, Weng H, Bennett DA, Boyle PA, Shah RC, Fague S, Hall CB, Lipton RB, Morris JC. Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease. Neuroepidemiology. 43: 131-9. PMID 25376544 DOI: 10.1159/000365733 |
0.444 |
|
| 2014 |
Kauwe JS, Bailey MH, Ridge PG, Perry R, Wadsworth ME, Hoyt KL, Staley LA, Karch CM, Harari O, Cruchaga C, Ainscough BJ, Bales K, Pickering EH, Bertelsen S, ... ... Morris JC, et al. Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation. Plos Genetics. 10: e1004758. PMID 25340798 DOI: 10.1371/Journal.Pgen.1004758 |
0.429 |
|
| 2014 |
Brier MR, Thomas JB, Snyder AZ, Wang L, Fagan AM, Benzinger T, Morris JC, Ances BM. Unrecognized preclinical Alzheimer disease confounds rs-fcMRI studies of normal aging. Neurology. 83: 1613-9. PMID 25261500 DOI: 10.1212/Wnl.0000000000000939 |
0.477 |
|
| 2014 |
Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Current Neurology and Neuroscience Reports. 14: 499. PMID 25217249 DOI: 10.1007/S11910-014-0499-8 |
0.423 |
|
| 2014 |
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Morris JC, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491 |
0.37 |
|
| 2014 |
Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, ... ... Morris JC, et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. Jama Neurology. 71: 1111-22. PMID 25069482 DOI: 10.1001/Jamaneurol.2014.1654 |
0.428 |
|
| 2014 |
Monsell SE, Mock C, Hassenstab J, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology. Neurology. 83: 434-40. PMID 24951474 DOI: 10.1212/Wnl.0000000000000650 |
0.47 |
|
| 2014 |
Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, ... ... Morris JC, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 83: 253-60. PMID 24928124 DOI: 10.1212/Wnl.0000000000000596 |
0.323 |
|
| 2014 |
Yang YH, Wang H, Lam L, Chan WC, Yu X, Li T, Wang WF, Chiu PY, Lin YT, Hu CJ, Fuh JL, Morris JC. Characteristics of Alzheimer's disease among patients in Taiwan, Hong Kong, and Beijing. Journal of Alzheimer's Disease : Jad. 42: 193-200. PMID 24840566 DOI: 10.3233/Jad-140174 |
0.417 |
|
| 2014 |
Wang L, Day J, Roe CM, Brier MR, Thomas JB, Benzinger TL, Morris JC, Ances BM. The effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging. Alzheimer Disease and Associated Disorders. 28: 122-7. PMID 24830360 DOI: 10.1097/Wad.0B013E318299D096 |
0.372 |
|
| 2014 |
Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, Ficker WD, Yan P, Xiong C, Frederiksen C, Grzelak MV, Chott R, Bateman RJ, Morris JC, Mintun MA, et al. An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice. Science Translational Medicine. 6: 236re4. PMID 24828079 DOI: 10.1126/Scitranslmed.3008169 |
0.432 |
|
| 2014 |
Dobrowolska JA, Kasten T, Huang Y, Benzinger TL, Sigurdson W, Ovod V, Morris JC, Bateman RJ. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system. Plos One. 9: e89998. PMID 24646516 DOI: 10.1371/Journal.Pone.0089998 |
0.384 |
|
| 2014 |
Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B. Harmonized diagnostic criteria for Alzheimer's disease: recommendations. Journal of Internal Medicine. 275: 204-13. PMID 24605805 DOI: 10.1111/Joim.12199 |
0.448 |
|
| 2014 |
Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, ... ... Morris JC, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30. PMID 24598588 DOI: 10.1126/Scitranslmed.3007901 |
0.5 |
|
| 2014 |
Harari O, Cruchaga C, Kauwe JS, Ainscough BJ, Bales K, Pickering EH, Bertelsen S, Fagan AM, Holtzman DM, Morris JC, Goate AM. Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid. Biological Psychiatry. 75: 723-31. PMID 24548642 DOI: 10.1016/J.Biopsych.2013.11.032 |
0.442 |
|
| 2014 |
Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert JC, Gibbs JR, Bras J, Sassi C, Harari O, Bertelsen S, Lupton MK, Powell J, ... ... Morris JC, et al. Missense variant in TREML2 protects against Alzheimer's disease. Neurobiology of Aging. 35: 1510.e19-26. PMID 24439484 DOI: 10.1016/J.Neurobiolaging.2013.12.010 |
0.419 |
|
| 2014 |
Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S, Jeng AT, Cooper B, Skorupa T, Carrell D, Levitch D, ... ... Morris JC, et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature. 505: 550-4. PMID 24336208 DOI: 10.1038/Nature12825 |
0.374 |
|
| 2014 |
Storandt M, Balota DA, Aschenbrenner AJ, Morris JC. Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology. 28: 19-29. PMID 24219606 DOI: 10.1037/Neu0000030 |
0.406 |
|
| 2014 |
Brier MR, Thomas JB, Fagan AM, Hassenstab J, Holtzman DM, Benzinger TL, Morris JC, Ances BM. Functional connectivity and graph theory in preclinical Alzheimer's disease. Neurobiology of Aging. 35: 757-68. PMID 24216223 DOI: 10.1016/J.Neurobiolaging.2013.10.081 |
0.466 |
|
| 2014 |
Xiong C, Luo J, Gao F, Morris JC. Optimizing parameters in clinical trials with a randomized start or withdrawal design. Computational Statistics & Data Analysis. 69: 101-113. PMID 24159249 DOI: 10.1016/J.Csda.2013.07.013 |
0.326 |
|
| 2014 |
Pizzie R, Hindman H, Roe CM, Head D, Grant E, Morris JC, Hassenstab JJ. Physical activity and cognitive trajectories in cognitively normal adults: the adult children study. Alzheimer Disease and Associated Disorders. 28: 50-7. PMID 23739296 DOI: 10.1097/Wad.0B013E31829628D4 |
0.342 |
|
| 2014 |
Morris JC. Dominantly inherited Alzheimer's disease, an opportunity for early intervention Neurobiology of Aging. 35. DOI: 10.1016/J.Neurobiolaging.2014.01.092 |
0.351 |
|
| 2014 |
Cairns N, Perrin RJ, Householder E, Carter D, Vincent B, Morris J. P1-318: NEUROPATHOLOGIC HETEROGENEITY IN ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI) SUBJECTS Alzheimer's & Dementia. 10: P428-P428. DOI: 10.1016/J.Jalz.2014.05.559 |
0.394 |
|
| 2014 |
Aschenbrenner AJ, Balota DA, Tse C, Fagan AM, Holtzman DM, Benzinger TL, Morris JC. P1-021: SYNERGISTIC AND MEDIATIONAL EFFECTS OF ALZHEIMER'S DISEASE BIOMARKERS ON A COGNITIVE MEASURE Alzheimer's & Dementia. 10: P311-P312. DOI: 10.1016/J.Jalz.2014.05.256 |
0.393 |
|
| 2014 |
Cash DM, Kinnunen KM, Leung KK, Ahsan L, Cardoso J, Modat M, Nicholas J, Malone I, Benzinger T, Jack CR, Thompson P, Saykin AJ, Sperling RR, Villemagne V, Weiner M, ... ... Morris J, et al. Longitudinal Rates Of Atrophy In Familial Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.112 |
0.36 |
|
| 2014 |
Risacher SL, West JD, Tallman EM, McDonald BC, Wang Y, Epperson F, Murrell J, Benzinger TL, Bateman R, Morris JC, Farlow MR, Ghetti BF, Saykin AJ. IC-P-094: ALTERED FMRI ACTIVATION PATTERN DURING VISUAL SCENE ENCODING IN AFFECTED AND NON-AFFECTED CARRIERS OF PSEN1 AND APP MUTATIONS Alzheimer's & Dementia. 10: P53-P53. DOI: 10.1016/J.Jalz.2014.05.099 |
0.315 |
|
| 2014 |
Wang Q, Roe C, Hildebolt C, Christensen J, Brewer J, Ances B, Morris J, Benzinger T. Combining Pet And Volumetric Mri To Improve Diagnoses Of Alzheimer Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.064 |
0.404 |
|
| 2014 |
Ghetti BF, Newell KL, Abrahamson EE, Cairns NJ, Murrell JR, Oblak AL, Unverzagt FW, Farlow MR, Epperson F, Richardson R, Dupree B, Morris JC, Klunk WE, Saykin AJ, Risacher SL, et al. IC-P-032: COMPARATIVE ANALYSIS OF PIB IN VIVO
WITH 6-CN-PIB AND Aβ-IMMUNOHISTOCHEMISTRY POSTMORTEM IN FAMILIAL ALZHEIMER DISEASE ASSOCIATED WITH THE PSEN1 I229F MUTATION Alzheimer's & Dementia. 10: P20-P21. DOI: 10.1016/J.Jalz.2014.05.036 |
0.371 |
|
| 2014 |
Vlassenko AG, Fagan AM, Jasielec MS, Su Y, Xiong C, Holtzman DM, Benzinger TL, Morris JC. IC-P-008: REGIONAL PIB DEPOSITION AND CSF Aβ42 LEVELS SEVERAL YEARS PRIOR TO AMYLOID POSITIVITY Alzheimer's & Dementia. 10: P11-P11. DOI: 10.1016/J.Jalz.2014.05.012 |
0.324 |
|
| 2014 |
Hassenstab J, Aschenbrenner A, Balota D, Dreyfus DM, Bateman R, Morris JC. O4-12-06: COGNITIVE PERFORMANCE IN THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN): BASELINE AND PRELIMINARY LONGITUDINAL FINDINGS Alzheimer's & Dementia. 10: P277-P277. DOI: 10.1016/J.Jalz.2014.04.456 |
0.345 |
|
| 2014 |
Ryman D, Morris J, Bateman R. Predicting Symptom Onset In Autosomal Dominant Alzheimer'S Disease: A Systematic Review And Meta-Analysis Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.299 |
0.331 |
|
| 2014 |
Morris JC, Weng J, Xiong C. S3-01-01: SCREENING FOR ALZHEIMER'S DISEASE IN COGNITIVELY NORMAL OLDER ADULTS: SUBJECTIVE COGNITIVE DECLINE VERSUS INFORMANT REPORT Alzheimer's & Dementia. 10: P200-P200. DOI: 10.1016/J.Jalz.2014.04.241 |
0.324 |
|
| 2013 |
Xiong C, van Belle G, Chen K, Tian L, Luo J, Gao F, Yan Y, Chen L, Morris JC, Crane P. Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease. Statistics in Biopharmaceutical Research. 5. PMID 24363827 DOI: 10.1080/19466315.2012.756662 |
0.402 |
|
| 2013 |
Toledo JB, Cairns NJ, Da X, Chen K, Carter D, Fleisher A, Householder E, Ayutyanont N, Roontiva A, Bauer RJ, Eisen P, Shaw LM, Davatzikos C, Weiner MW, Reiman EM, ... Morris JC, et al. Clinical and multimodal biomarker correlates of ADNI neuropathological findings. Acta Neuropathologica Communications. 1: 65. PMID 24252435 DOI: 10.1186/2051-5960-1-65 |
0.505 |
|
| 2013 |
Su Y, D'Angelo GM, Vlassenko AG, Zhou G, Snyder AZ, Marcus DS, Blazey TM, Christensen JJ, Vora S, Morris JC, Mintun MA, Benzinger TL. Quantitative analysis of PiB-PET with FreeSurfer ROIs. Plos One. 8: e73377. PMID 24223109 DOI: 10.1371/Journal.Pone.0073377 |
0.425 |
|
| 2013 |
Roe CM, Fagan AM, Grant EA, Holtzman DM, Morris JC. CSF biomarkers of Alzheimer disease: "noncognitive" outcomes. Neurology. 81: 2028-31. PMID 24212387 DOI: 10.1212/01.Wnl.0000436940.78152.05 |
0.461 |
|
| 2013 |
Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, ... ... Morris JC, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E4502-9. PMID 24194552 DOI: 10.1073/Pnas.1317918110 |
0.393 |
|
| 2013 |
Moulder KL, Snider BJ, Mills SL, Buckles VD, Santacruz AM, Bateman RJ, Morris JC. Dominantly Inherited Alzheimer Network: facilitating research and clinical trials. Alzheimer's Research & Therapy. 5: 48. PMID 24131566 DOI: 10.1186/Alzrt213 |
0.469 |
|
| 2013 |
Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, ... ... Morris JC, et al. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology. 81: 1425-33. PMID 24049139 DOI: 10.1212/Wnl.0B013E3182A841C6 |
0.411 |
|
| 2013 |
Duchek JM, Balota DA, Thomas JB, Snyder AZ, Rich P, Benzinger TL, Fagan AM, Holtzman DM, Morris JC, Ances BM. Relationship between Stroop performance and resting state functional connectivity in cognitively normal older adults. Neuropsychology. 27: 516-28. PMID 24040929 DOI: 10.1037/A0033402 |
0.407 |
|
| 2013 |
Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, ... ... Morris JC, et al. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Revue Neurologique. 169: 737-43. PMID 24016464 DOI: 10.1016/J.Neurol.2013.07.017 |
0.373 |
|
| 2013 |
Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. The Lancet. Neurology. 12: 957-65. PMID 24012374 DOI: 10.1016/S1474-4422(13)70194-7 |
0.486 |
|
| 2013 |
Benitez BA, Karch CM, Cai Y, Jin SC, Cooper B, Carrell D, Bertelsen S, Chibnik L, Schneider JA, Bennett DA, Fagan AM, Holtzman D, Morris JC, et al. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers. Plos Genetics. 9: e1003685. PMID 23990795 DOI: 10.1371/Journal.Pgen.1003685 |
0.385 |
|
| 2013 |
Wang L, Brier MR, Snyder AZ, Thomas JB, Fagan AM, Xiong C, Benzinger TL, Holtzman DM, Morris JC, Ances BM. Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity. Jama Neurology. 70: 1242-8. PMID 23959173 DOI: 10.1001/Jamaneurol.2013.3253 |
0.402 |
|
| 2013 |
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: e111-94. PMID 23932184 DOI: 10.1016/j.jalz.2013.05.1769 |
0.41 |
|
| 2013 |
Frost SM, Kanagasingam Y, Sohrabi HR, Taddei K, Bateman R, Morris J, Benzinger T, Goate A, Masters CL, Martins RN. Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers. Current Alzheimer Research. 10: 790-6. PMID 23919771 DOI: 10.2174/15672050113109990154 |
0.36 |
|
| 2013 |
Chhatwal JP, Schultz AP, Johnson K, Benzinger TL, Jack C, Ances BM, Sullivan CA, Salloway SP, Ringman JM, Koeppe RA, Marcus DS, Thompson P, Saykin AJ, Correia S, Schofield PR, ... ... Morris JC, et al. Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology. 81: 736-44. PMID 23884042 DOI: 10.1212/Wnl.0B013E3182A1Aafe |
0.396 |
|
| 2013 |
Stark SL, Roe CM, Grant EA, Hollingsworth H, Benzinger TL, Fagan AM, Buckles VD, Morris JC. Preclinical Alzheimer disease and risk of falls. Neurology. 81: 437-43. PMID 23803314 DOI: 10.1212/Wnl.0B013E31829D8599 |
0.481 |
|
| 2013 |
Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, Mawuenyega K, Blazey T, Goate A, Chott R, Yarasheski KE, Holtzman DM, Morris JC, Benzinger TL, Bateman RJ. Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers. Science Translational Medicine. 5: 189ra77. PMID 23761040 DOI: 10.1126/Scitranslmed.3005615 |
0.371 |
|
| 2013 |
Wilkins CH, Roe CM, Morris JC, Galvin JE. Mild physical impairment predicts future diagnosis of dementia of the Alzheimer's type. Journal of the American Geriatrics Society. 61: 1055-9. PMID 23647233 DOI: 10.1111/Jgs.12255 |
0.418 |
|
| 2013 |
Monsell SE, Mock C, Roe CM, Ghoshal N, Morris JC, Cairns NJ, Kukull W. Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology. Neurology. 80: 2121-9. PMID 23645594 DOI: 10.1212/Wnl.0B013E318295D7A1 |
0.469 |
|
| 2013 |
Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TL, Mintun MA, Holtzman DM, Morris JC. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology. 80: 1784-91. PMID 23576620 DOI: 10.1212/Wnl.0B013E3182918Ca6 |
0.445 |
|
| 2013 |
Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D, Bertelsen S, Bailey M, McKean D, Shulman JM, De Jager PL, ... ... Morris JC, et al. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 78: 256-68. PMID 23562540 DOI: 10.1016/J.Neuron.2013.02.026 |
0.413 |
|
| 2013 |
Bakkour A, Morris JC, Wolk DA, Dickerson BC. The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition. Neuroimage. 76: 332-44. PMID 23507382 DOI: 10.1016/J.Neuroimage.2013.02.059 |
0.426 |
|
| 2013 |
Shim YS, Roe CM, Buckles VD, Morris JC. Clinicopathologic study of Alzheimer's disease: Alzheimer mimics. Journal of Alzheimer's Disease : Jad. 35: 799-811. PMID 23481687 DOI: 10.3233/Jad-121594 |
0.474 |
|
| 2013 |
Ju YE, McLeland JS, Toedebusch CD, Xiong C, Fagan AM, Duntley SP, Morris JC, Holtzman DM. Sleep quality and preclinical Alzheimer disease. Jama Neurology. 70: 587-93. PMID 23479184 DOI: 10.1001/Jamaneurol.2013.2334 |
0.319 |
|
| 2013 |
Dong Y, Pang WS, Lim LB, Yang YH, Morris JC, Hilal S, Venketasubramanian N, Chen CL. The informant AD8 is superior to participant AD8 in detecting cognitive impairment in a memory clinic setting. Journal of Alzheimer's Disease : Jad. 35: 159-68. PMID 23380993 DOI: 10.3233/Jad-122026 |
0.434 |
|
| 2013 |
Borson S, Frank L, Bayley PJ, Boustani M, Dean M, Lin PJ, McCarten JR, Morris JC, Salmon DP, Schmitt FA, Stefanacci RG, Mendiondo MS, Peschin S, Hall EJ, Fillit H, et al. Improving dementia care: the role of screening and detection of cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 151-9. PMID 23375564 DOI: 10.1016/J.Jalz.2012.08.008 |
0.366 |
|
| 2013 |
Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, ... ... Morris J, et al. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 189-98. PMID 23062850 DOI: 10.1016/J.Jalz.2012.03.003 |
0.325 |
|
| 2013 |
Boxer AL, Gold M, Huey E, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, ... ... Morris J, et al. Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 176-88. PMID 23043900 DOI: 10.1016/J.Jalz.2012.03.002 |
0.378 |
|
| 2013 |
Williams MM, Storandt M, Roe CM, Morris JC. Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: S39-44. PMID 22858530 DOI: 10.1016/J.Jalz.2012.01.005 |
0.45 |
|
| 2013 |
Welsh-Bohmer KA, Fillenbaum GG, Morris JC. Albert Heyman, MD (1916-2012) Neurology. 80: 1184-1185. DOI: 10.1212/Wnl.0B013E3182897160 |
0.374 |
|
| 2013 |
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Morris JC, et al. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics. 45: 712-712. DOI: 10.1038/Ng0613-712A |
0.358 |
|
| 2013 |
Ruvolo D, Chasse R, Dreyfus DM, Vernon E, Grant E, Morris J, Hassenstab J. Attenuation of practice effects on neuropsychological performance is a potential marker of preclinical Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.08.222 |
0.376 |
|
| 2013 |
Chasse R, Benzinger T, Grant E, Cairns N, Fagan A, Morris J, Hassenstab J. Alzheimer's disease biomarkers and normative cognitive data: The SuperNorms approach Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.08.220 |
0.43 |
|
| 2013 |
Wang L, Brier M, Snyder A, Thomas J, Fagan A, Xiong C, Benzinger T, Holtzman D, Morris J, Ances B. P2-159: Cerebrospinal fluid beta-amyloid 42, tau, phosphorylated tau 181, and resting state functional connectivity Alzheimer's & Dementia. 9: P405-P406. DOI: 10.1016/J.Jalz.2013.05.804 |
0.309 |
|
| 2013 |
Thomas J, Brier M, Bateman R, Snyder A, Benzinger T, Xiong C, Raichle M, Sperling R, Mayeux R, Ghetti B, Ringman J, Salloway S, McDade E, Rossor M, Schofield P, ... ... Morris J, et al. IC-P-184: Resting state functional connectivity in autosomal dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 9: P105-P105. DOI: 10.1016/J.Jalz.2013.05.181 |
0.371 |
|
| 2013 |
Cruchaga C, Harari O, Kauwe J, Bales K, Pickering EH, Bertelsen S, Fagan A, Holtzman D, Morris J, Goate A. P4-002: Cerebrospinal heart fatty-acid-binding protein as a biomarker for Alzheimer's disease Alzheimer's & Dementia. 9: P705-P705. DOI: 10.1016/J.Jalz.2013.05.1390 |
0.332 |
|
| 2013 |
Wang L, Ercole L, Blazey T, Benzinger T, Hassenstab J, Morris J, Ances B. IC-P-114: A refined cortical signature of Alzheimer's disease Alzheimer's & Dementia. 9: P69-P69. DOI: 10.1016/J.Jalz.2013.05.111 |
0.36 |
|
| 2013 |
Gordon B, Blazey T, Allison S, Morris J, Benzinger T, Head D. IC-P-104: Characterization of cortical microstructural changes in Alzheimer's disease Alzheimer's & Dementia. 9: P60-P60. DOI: 10.1016/J.Jalz.2013.05.101 |
0.551 |
|
| 2013 |
Blazey T, Jack C, Kantarci K, Preboske G, Ringman J, Brickman A, Raichle M, Hornbeck R, Saykin A, Salloway S, McDade E, Rossor M, Fox N, Thompson P, Correia S, ... ... Morris J, et al. Prevalence and growth of cerebral microhemorrhages in autosomal dominant Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.100 |
0.357 |
|
| 2013 |
Brier M, Thomas J, Fagan A, Holtzman D, Benzinger T, Morris J, Ances B. IC-P-085: Early pathological changes due to Alzheimer's disease are detected by graph theoretical measures of functional connectivity Alzheimer's & Dementia. 9: P50-P50. DOI: 10.1016/J.Jalz.2013.05.082 |
0.364 |
|
| Show low-probability matches. |
